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Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. TBI is most 
prevalent in people during their productive years and frequently results in prolonged or life-
long motor and/or cognitive impairments, putting a significant economic burden on society. 
Mild TBI (mTBI), comprising over 80% of TBI cases, frequently results in acute neurosensory 
deficits and subacute ongoing neurological deficits with long-term implications, including the 
potential development of neurodegenerative diseases. Factors including the age at injury, sex, 
number of injuries and interval between injuries have the potential to affect pathological 
changes and the recovery process following mTBI, however, how these factors interact 
remains unclear. Therefore, the underlying cellular and subcellular responses evoked by mTBI 
need to be fully elucidated in order to understand how these factors affect outcomes following 
mTBI, and furthermore to develop effective therapeutic interventions. The current thesis is 
based on the hypothesis that specific cellular and subcellular responses (including neuronal 
and glial changes) differentially characterize pathological changes and recovery processes 
after mTBI.  
This thesis investigated how the age at injury affects outcomes after mTBI. Studies focused 
on the cellular and subcellular reactions after injury. Studies found non-injured aged brains 
were characterized with cortical atrophy, higher astrocyte and microglial activation, as well as 
increased axonal degeneration compared to younger brains. Furthermore, using a mild lateral 
fluid percussion injury mouse model, results showed that although select cortical changes 
after injury were independent of the age at injury, astrocytic and microglial activation, as well 
as axonal degeneration after injury were age and post injury time interval dependent. This 
thesis suggests that the cellular and subcellular responses after mTBI are age dependent. 
This thesis further investigated a potential drug intervention for mTBI. Neuronal cytoskeletal 
changes, including the morphological and functional changes of microtubules are recognized 
as a pathological feature of degeneration after TBI. Thus, I hypothesized that a microtubule 
stabilizing agent would have beneficial therapeutic potential following TBI. This study found 
that epothilone D was not toxic to cortical neurons and did not have any significant effects on 
the glial response in young and adult mice. With regards to axonal degeneration, in young 
mice that received a mTBI injury and subsequent EpoD treatment, measures of axon 
degeneration were also found to be similar compared to untreated animals. In older animals, 
however, the measures of axon degeneration were worse in injured animals after EpoD 
treatment compared to untreated injured animals. This thesis highlights the need for age 
dependent drug therapy for mTBI patients. 
viii 
Finally, this thesis investigated how sex and an additional injury influence the outcome after 
mTBI. Conflicting literature exists regarding whether females have better outcomes than 
males in both experimental and clinical studies of TBI. Our results suggest that glial activation 
was distinctive between sexes, as well as different axonal degeneration between sexes with 
increased axonal degeneration after injury resolving earlier in females but exacerbated in male 
mice. Furthermore, our study also found a second injury, 48 hours following the first, 
significantly increased glial activation, as well as reduced the cortical thickness and 
exacerbated axonal degeneration after injury in male mice. This thesis suggested both sex 
and an additional injury differentially affected glial and axonal responses, which may further 
support the need for sex dependent and repetitive injury dependent clinical management of 
mTBI patients. 
In summary, this thesis shows how risk factors including age at injury, sex and a second injury 
effected the cellular and subcellular reaction following mTBI in a mouse model. Furthermore, 
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1. INTRODUCTION
Traumatic brain injury (TBI) is a non-congenital insult to the brain from an external mechanical 
force that can potentially lead to temporary or permanent impairment of cognitive, physical, 
and psychosocial functions (Syed et al., 2007). Most of the neurological impairments from TBI 
evolve over hours and days after the initial injury, which allows TBI to be divided into primary 
and secondary brain injury. Primary injury results from mechanical injury at the time of injury, 
and includes both focal and diffuse injuries. Secondary injury occurs hours or even days after 
the initial injury, and is caused by the physiologic responses to the initial impact (Al-Sarraj, 
2016) (see Fig 1.1). TBI is a significant public health problem as it is a major cause of death 
and disability worldwide (Xu, 2017). It is reported that 50-60 million people worldwide 
(including at least 3.5 million in the US, and 2.5 million in Europe) are affected by TBI each 
year, the great majority of cases are mild TBI (Maas et al., 2017). In Australia, the overall 
incidence of TBI cases per 100,000 population is 99.1 in New South Wales (Pozzato et al., 
2019), whilst in New Zealand, the total incidence of TBI per 100,000 person-years of is 749 
cases for mTBI and 41 cases for moderate to severe (Feigin et al., 2013). TBI can occur at 
any age, with young children aged 0-4 years, older adolescents aged 15-19 years, and adults 
aged over 75 years having the highest incidence rates (Xu, 2017). TBI can be classified 
according to severity into mild, moderate or severe forms, with the vast majority of TBI cases 
being mild TBI (mTBI). The classification of mTBI has been a matter of controversy, which 
makes comparison of studies difficult (Lefevre-Dognin et al., 2020). In general patients, mTBI 
is diagnosed with a GCS score of 13-15. However, other clinical factors have been considered 
in the classification of mild TBI, such as loss of consciousness (Katz and Alexander, 1994), 
as well as the consideration of neuroimaging findings (Williams et al., 1990). The diagnosis of 
concussion resulting from a sporting injury is different, and depends on the severity of the 
neurologic dysfunction and the extent of the diagnostic testing (McCrory et al., 2017). Although 
the terms ‘mild TBI’ and ‘concussion’ are used interchangeably in trauma literature, it's still a 
debate as whether mTBI is synonymous with concussion or not, with ‘mTBI’ used in general 
medical contexts and ‘concussion’ more commonly used in the context of sports injuries 
(Greenwald et al., 2012). Clinically, mTBI is classified as an injury where post-traumatic 
amnesia or alteration of consciousness is less than or equal to 24hrs; the length of loss of 
consciousness is less than or equal to 30 min; and/or with Glasgow Coma Scale (GCS) 13-
15 (Benzinger et al., 2009). mTBI is extremely common worldwide, with around 42 million 
people seeking medical attention for this condition each year (Gardner and Yaffe, 2015). 
Moreover, the financial burden of mTBI is extensive, with the cost of mTBI in the US military 
population alone rising extensively to around $250 million per year (McCrea, 2008). According 
to a population based study of TBI in New Zealand, the major cause of mTBI is falls (38%), 
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other causes include exposure to mechanical force (22%), transport accidents (19%), assault 
(17%) and other causes (4%) (Feigin et al., 2013). Populations involved in contact sports, 
military personnel and victims of domestic violence are at high risk for suffering mTBI (Gardner 
and Yaffe, 2015). Additionally, the estimates of the incidence of sport-related mTBI range from 
1.6-3.8 million per year in the US (Langlois et al., 2006). Sex dependent incidence exists with 
regards to the susceptibility of TBI (Faul and Coronado, 2015), with women more likely to be 
injured during an assault or violence while men are most often injured due to falls and motor 
vehicle accidents (Iverson et al., 2011, Colantonio, 2016). Multiple injuries have been 
observed in individuals, particularly among war injured veterans and sport-injured athletes, 
which has resulted in repetitive mTBI (rmTBI) becoming an area of research focus. 
 
Unlike moderate and severe TBI, individuals with mTBI often show cognitive impairments 
without identifiable tissue lesions or cavities in the cerebral cortex, even when using traditional 
neuroimaging techniques including magnetic resonance imaging (MRI) and computed 
tomography (CT) (Gao and Chen, 2011). Therefore, mTBI has been termed an invisible and 
silent epidemic. In the clinic, mTBI is typically characterized by a transient disturbance in brain 
function, with short-lasting neurological symptoms including headaches, dizziness and 
confusion (Carroll et al., 2004). Even though symptoms for the majority of patients subside 
within short-term after injury (Rivara and Graham, 2014), a proportion of patients may develop 
with persisting post-concussive symptoms (PPCS) (Vasterling et al., 2009, Anderson et al., 
2017, Keenan et al., 2018), with long-lasting behavioural and cognitive deficits (Kraus et al., 
2007). Additionally, mTBI may also be associated with an increased risk of developing 
neurodegenerative diseases later on in life, including Alzheimer’s disease (AD) and 
Parkinson’s disease (PD) (DeKosky et al., 2010). mTBI is an evolving and dynamic injury, in 
which injury forces induce physical stress in the brain that initiates a complex series of 
neurochemical and metabolic changes (Taber and Hurley, 2013). As it is shown in Fig 1.1, 
immediately after a brain insult, there are brain swelling; ischemia caused by decreased 
cerebral blood flow; excitotoxicity due to the release of excessive excitatory neurotransmitters; 
calcium-mediated brain damage, oedema and mitochondrial dysfunction that generates 
energy failure and excessive free-radical generation (Gupta and Przekwas, 2013). Moreover, 
injury also initiated necrotic and apoptotic neuronal cell death (Büki and Povlishock, 2006, 
Saatman et al., 2008). There are two main types of oedema, vasogenic and cytotoxic brain 
edema. Vasogenic edema relates to blood brain barrier (BBB) disruption, it occurs when the 
BBB is disrupted allowing an influx of plasma from the vasculature into the extracellular space 
(Peters and Vaughn, 1967). Cytotoxic edema is related with a failure in ATP-dependent 
multiple ion pumps (mainly Na+/K+-pumps) during energy shortage, it increases in water 
content within the intracellular compartment as a result of an osmotic gradient and cell swelling 
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(Kochanek et al., 2000). Although growing knowledge on the short and long-term behavioural 
and cognitive deficits after mTBI has been gained, the underlying mechanisms are still yet to 
be fully understood. 
 
 
Figure 1.1. Primary and secondary injury mechanisms. 
Schematic representation of post-injury mechanisms activated after an initial traumatic injury 
to the brain (Adapter from Gupta and Przekwas, 2013) 
 
Pathological and behavioural changes after TBI are likely to be heterogeneous, and influenced 
by many factors. Cellular and sub-cellular changes could both contribute to brain pathology. 
Factors that could potentially affect these changes, as well as recovery process after mTBI, 
include the age at injury, sex, as well as the number of injuries and interval between injuries. 
Compelling studies have found aged adults are particularly vulnerable to TBI with increased 
cognitive and behavioural dysfunction, as well as higher morbidity and mortality rates 
(Pannese, 2011, Popa-Wagner et al., 2011). The underlying mechanisms causing this may 
be associated with the properties of the aged brain itself, including decreased brain plasticity 
(Sapoznik et al., 2006), a shift from balanced homeostatic inflammatory state to a pro-
inflammatory state (Popa-Wagner et al., 2011), as well as increased cellular and subcellular 
dysfunction (Timaru-Kast et al., 2015). In children, injury to the brain may be viewed as more 
complex as the brain is still developing. Historically, the brain of a child was considered to 
have a higher capacity for plasticity, which was thought to favor recovery from brain injury 
(Johnston et al., 2009, Kolb and Gibb, 2011). However, with regard to mTBI, there are a 
proportion children that present with delayed deficits despite an apparent return to normality 
acutely after injury (Karver et al., 2012, Eisenberg et al., 2014). In addition, it has been 
observed that many children do not fully recover and have persisting PPCS weeks, months, 
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and even years after injury (Anderson et al., 2017, Keenan et al., 2018). Therefore, whether 
the young are protected from or vulnerable to mTBI is still controversial. Similarly, the literature 
is mixed with regard to explaining how sex influences the cellular reactions after TBI. Clinical 
studies of mild and moderate brain injuries among female general patients and sports injuries 
have found that injuries in females resulted in significantly worse outcomes, those include 
higher somatic and motor symptoms, increased difficulties with memory and cognition, and 
higher levels of depression at 6 months post mild to moderate injury, as well as higher 
drowsiness and sensitivity to noise at 1 year after mild injury (Dick, 2009, Preiss-Farzanegan 
et al., 2009, Bazarian et al., 2010, Frommer et al., 2011, Laker, 2011, Covassin and Bay, 
2012). However, the major experimental studies report female animals with better recovery 
than male animals after brain injury (Gupte et al., 2019). The number of injuries, and interval 
between them are another risk factor for mTBI. Animal studies modeling rmTBI using various 
number of injuries and interval between injuries, suggested short-time interval between 
injuries exacerbated injury pathology (Grant et al., 2018, Mouzon et al., 2018a), while others 
found the interval between injuries did not have any additional effects (Fujita et al., 2012, Hall 
et al., 2016). The complex and inconclusive clinical and/or experimental findings on how these 
risk factors influence the pathological changes and recovery process after mTBI suggest that 
more studies are warranted. 
 
1.1. MILD TRAUMATIC BRAIN INJURY 
 
Even though there is no overt brain damage following mTBI, the initial physical stretch and 
stress to the brain can potentially initiate a pathophysiological cascade in the brain, in which 
neuroinflammation, brain edema, hypometabolism, and vascular injuries occur (Blennow et 
al., 2012, Jordan, 2013). Additionally, behavior and motor function deficits, as well as cognitive 
impairments have been reported at both short-term and long-term after mTBI (Kraus et al., 
2007, Tay et al., 2010). These deficits after mTBI may be caused by cellular, sub-cellular, and 
molecular reactions, which are still under active investigation and are yet to be fully elucidated. 
 
1.1.1. The neuronal reaction to mTBI  
 
Neurons have a distinct morphology with a soma, an axon and dendrites. At its simplest, the 
axon transmits signal from one neuron to the terminals of another neuron, where it forms 
synapses with neuronal connections and information is converted. Dendrites receive 
connections from other neurons which act to propagate the electrochemical stimulation on the 
neuronal surface through synapses (Brodal, 2004). The synapse consists of a pre-synapse, 
synaptic cleft and post-synapse. Synaptophysin and post synaptic density protein 95 (PSD-
 5 
95) can be used as presynaptic and postsynaptic markers, respectively. Synaptophysin is a 
calcium binding glycoprotein (38,000KD), and is an integral membrane protein localized to 
synaptic vesicles (Wiedenmann et al., 1986). PSD-95, a member of the membrane associated 
guanylate kinase family, accumulates at the post synaptic density of neurons which binds 
excitatory receptors (Hunt et al., 1996). Spines are the dendritic membranous protrusions 
used for synaptic strength and electrical transmission. There are hundreds to thousands of 
spines on a neuron. They can be classified into three categories: mushroom, stubby and thin 
spines according to their shapes and lengths (Fig 1.2) (Harris et al., 1992). Mushroom spines 
have a large head but a small neck and are usually regarded as mature spines (Harris et al., 
1992), whereas thin spines are long and fine and are regarded as immature and unstable 
spines (Petrak et al., 2005). Stubby spines are usually regarded as the transitional stage 
between mushroom and thin spines. Spines are an important formation of synapses, of which 
the plasticity including long-term potentiation and depression, are essential for learning and 
memory. The proportion of mature/immature spines is vital for synaptic signaling and 
alterations in dendritic spine density have been inversely linked to cognitive function (Penzes 
et al., 2011). In the context of moderate and severe TBI, neuronal degeneration and death, 
dendritic beading and fragmentation, as well as spine and synapse reduction have been 
observed not only at the injury site, but also in remote areas distal to the injury site including 
hippocampus and contralateral cortex (Gao et al., 2011, Winston et al., 2013, Zhao et al., 
2015, Zhao et al., 2016). With regard to mTBI, one report states that the injury did not cause 
overt neuron death and left the cortex intact without cavity, however, it was found the injury 
caused dendritic beading in the peri-injury cortex at early as 2hrs post-injury (Sword et al., 
2013). It was also observed that mild injury induced dendrite and spine degeneration, as well 
as an decrease in the number of synapses in the injured cortex at 3 days post-injury (Gao and 
Chen, 2011), additionally, at the same time point after mild injury, a significant decrease in 
dendritic density, as well as dendritic branching were reported in the parietal cortex (Ratliff et 
al., 2020). Injury related dendritic damage may extend beyond the injured area, at 3 days post 
injury, a reduction in dendritic density as well as dendritic branching were observed in the 
hippocampus (Ratliff et al., 2020). At 32 days after mild injury, decrease in spine density was 







Figure 1.2 Dendritic spines classification. 
 
Dendritic spines are grouped into three classes: thin, mushroom, and stubby spines 
according to their shape and appearance (Adapted from Rodriguez et al., 2008) 
 
Axons are long projections, which are used to conduct electrical impulses and are vital for 
neuronal transmission. The neuronal cytoskeleton, comprising microtubules, actin filaments 
and neurofilaments (NFs), plays an important role in the establishment, remolding and 
maintenance of neuronal architecture, as well as the morphology and integrity of axons 
(Conde and Cáceres, 2009, Kapitein and Hoogenraad, 2011). NFs play an important role in 
controlling axonal diameter and conductance (Yuan et al., 2012), while microtubules and actin 
filaments are mainly involved in axonal specification and growth, as well as long- and short-
distance active axonal transport (Sainath and Gallo, 2015). Axons are susceptible to brain 
injury with long axonal projections in the white matter tracts, and the unmyelinated axon in the 
brain is particularly vulnerable (Johnson et al., 2013b, Smith et al., 2013a, Wong et al., 2017). 
TBI can cause damage to axons throughout the white matter, which is identified as diffuse 
axonal injury (DAI). It is a pathological hallmark of TBI (Frati et al., 2017), and has been widely 
observed in moderate and severe TBIs (Vieira et al., 2016, Rabinowitz et al., 2018). DAI 
encompasses a spectrum of primary mechanical breaking of the axonal cytoskeleton to 
transport interruption, through secondary physiological changes. Additionally, it is 
characterized by axonal swellings or varicosities, large terminal bulb formations, and may 
finally lead to secondary axotomy and axonal disconnection (Smith et al., 2003, Johnson et 
al., 2013b). Immunohistochemical identification of Amyloid Precursor Protein (APP) 
accumulation in damaged axons is the gold-standard neuropathological approach for the 
diagnosis of DAI post-mortem (Sherriff et al., 1994, Johnson et al., 2013b). In severe TBI, the 
initial injury force may induce immediate axonal disconnection, however, this is rare in mTBI 
(Johnson et al., 2013b). With regard to mTBI, axonal swelling was observed dispersed across 
the neocortex at 2 days after injury in mice (Vascak et al., 2017). Moreover, significantly higher 
βAPP positive axons within the corpus callosum was observed at 2 hrs and 48 hrs after injury 
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in mice (Henninger et al., 2016). At 1 week post injury, degenerating axon terminals detected 
by silver staining were observed within the corpus callosum, entorhinal cortex, cerebra 
peduncle and fornix in mice (Chen et al., 2018). Likewise, higher axonal degeneration in the 
external capsule and internal capsule was also observed at 7 days post injury in mice 
(Chuckowree et al., 2018). At longer timepoint, electron microscopy revealed degenerating 
axons among intact fibers in the corpus callosum at 6 weeks post injury in mice (Mierzwa et 
al., 2015). These axonal changes have been suggested to correlate with functional, cognitive 
and emotional impairments (Hellstrøm et al., 2017). Therefore, with regard to mTBI, it has 
been proposed that the primary stretching force disrupts axonal membranes, and the 
secondary metabolic and ionic dysfunction may then affect the axonal cytoskeleton, disrupt 
axonal transport, and form swellings in contiguous axons, which finally causes axonal 
disconnection (Johnson et al., 2016). Axonal myelin may also be disrupted and degraded after 
TBI, which may trigger and exacerbate neuroinflammation as the debris may be stimulating 
microglial activation (Vargas and Barres, 2007, Clarner et al., 2012).  
 
1.1.2. The astrocyte reaction to mTBI  
 
Astrocytes are star-shaped glial cells in the brain. They contain a density of intermediate 
filaments, such as glial fibrillary acidic protein (GFAP) which has been used as a marker for 
astrocyte activation. GFAP is markedly up-regulated after TBI and stroke (Liu et al., 2014, Yu 
et al., 2016), additionally, levels of GFAP are suggested to be correlated with the severity of 
TBI and could be used as a predictor for outcomes after TBI (Luoto et al., 2017, Hossain et 
al., 2019). In healthy brains, astrocytes play vital roles in neural circuit function by maintaining 
the homeostasis of water, ions, blood flow and neurotransmitters (Sofroniew and Vinters, 
2010, Pekny and Pekna, 2014). Additionally, they are the pivotal responders to all forms of 
brain insults. After a TBI, astrocytes become activated, a process referred to as reactive 
astrogliosis. These activated astrocytes may be beneficial by protecting neural tissue through 
isolating the lesion, and restraining the damage (Hamlin et al., 2001). Additionally, they are 
involved in inflammation and blood brain barrier (BBB) regulation, as well as synapse 
formation and function (Burda et al., 2016). However, astrocytes may become detrimental by 
producing pro-inflammatory cytokines and chemokines, which could cause further damage to 
the brain (Burda et al., 2016). Astrocyte activation could be long-lasting with activated 
astrocytes in the cortex and hippocampus 6 months after TBI reported (Mouzon et al., 2014). 
In the context of mTBI, reactive astrogliosis and hypertrophic astrocytes have also been 
observed in various regions, including the injured cortex, corpus callosum, and hippocampus 
after acute and chronic injuries (Goodrich et al., 2016, Rodriguez-Grande et al., 2018), which 
could partially contribute to post-TBI dysfunction (Burda et al., 2016). Excitotoxicity is a 
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common component of secondary brain injury after mTBI (Mayeux et al., 2017, Shokouhi et 
al., 2020), which could be detrimental to neurons. Astrocytes provide functional support for 
neurons by recycling of the glutamate from synapses, thus to prevent the accumulation of 
extracellular glutamate, in which the glutamate transporters, such as EAAT1 and EAAT2 are 
required (Chen and Swanson, 2003). 
 
1.1.3. The microglia reaction to mTBI  
 
Microglia are myeloid-derived cells (Ransohoff and Perry, 2009), which are a type of neuroglia 
located in the brain and spinal cords. Microglia are involved in synaptic pruning, central 
nervous system (CNS) repair and immune defense. Ionized calcium binding adaptor molecule 
1 (Iba1) is a protein whose expression is specific to microglia/macrophages (Imai et al., 1996). 
Although its expresssion is thought to increase with microlial activation, it is considered as a 
marker of all microglia, rather than an acitivated subset (Walker and Lue, 2015). Iba1 
expression is upregulated in activated microglia following TBI (Gao et al., 2015, Woodcock 
and Morganti-Kossmann, 2015). In response to TBI, microglia can migrate to the injury site, 
build a protective environment and alleviate the deleterious sequelae of brain injury (Faden et 
al., 2016). The acute function of microglia involves removing the cellular and molecular debris, 
in order to restore the normal environment of the brain (Faden et al., 2016, Donat et al., 2017). 
However, microglia can also become dysregulated, produce high levels of pro-inflammatory, 
noxious substances and cytotoxic mediators, that contribute to neuronal dysfunction, cell 
death, and affect synaptic plasticity and cognition (Loane and Kumar, 2016). Microglial 
activation could be long-lasting with observations of activated microglia within the injured 
cortex and hippocampus at 6 months and even up to 1 year after brain injury (Mouzon et al., 
2014, Norden et al., 2015). In the context of mild TBI, microglial reactivity has also been 
reported in the cortex, corpus callosum and hippocampus after acute and chronic injury 
(Lafrenaye et al., 2015, Goodrich et al., 2016).  
 
1.2. AGE AT INJURY AS A RISK FACTOR FOR mTBI 
 
The elderly population is growing worldwide, compelling studies have revealed that the ageing 
process is associated with increased CNS vulnerability evidenced by an increasing rate of 
cognitive decline, neurological dysfunctions, mortality and morbidity (Pannese, 2011, Popa-
Wagner et al., 2011). The mechanism underlying this vulnerability may be relevant to the brain 
changes during ageing. These changes include brain atrophy (Pannese, 2011), a reduction in 
brain plasticity (Petralia et al., 2014, Seib and Martin-Villalba, 2015), a pro-inflammatory state 
(Popa-Wagner et al., 2011), higher oxidative stress due to increased oxidative substance 
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production and decreased antioxidative generation (Romano et al., 2010), as well as 
metabolism disruption with decreased glucose uptake and increased mitochondrial 
dysfunction (Craft, 2005). Clinical data strongly suggests elderly individuals account for a 
disproportionately high incidence of TBI that is associated with poorer outcomes, with the 
oldest having the poorest outcomes after TBI, along with slower rehabilitation(Cheng et al., 
2014b, Seagly et al., 2018), which causes them fall behind younger patients (Mosenthal et al., 
2004). The potential underlying mechanisms may include less compensatory neurons and 
higher systemic complications suggested by clinical findings (Davis et al., 2011), as well as 
higher oxidative damage and higher mitochondrial dysfunction suggested by experimental 
studies (Gilmer et al., 2010, Itoh et al., 2013).  
 
Children’s brains are still undergoing development, with brain connections being formed and 
pruned, in order to gain new functions and shape the brain. TBI in children was previously 
thought to be offset by their adaptive properties, among which, plasticity is one of the most 
predominant adaptive factors. Plasticity enables the brain to adapt to brain injury through 
modulating genetic, molecular and cellular mechanisms, and then affect synaptic connections 
and neural circuitry formation (Johnston, 2004, Lau and Zukin, 2007), which may increase 
impact tolerance as well as benefit the recovery process (Chen et al., 2015). This plasticity is 
suggested by abundant neural stem cells, quicker toxic protein (such as amyloid beta) 
removal, and quicker metabolism recovery in young brains (Venkitaramani et al., 2007, Deng-
Bryant et al., 2011, Zhang et al., 2017b). In the context of mTBI, some children may fully 
recover within the first few days or weeks post injury, however, a proportion of children do not 
recover and develop post-concussive symptoms which may persist even years after injury 
(Anderson et al., 2017, Keenan et al., 2018). These long-lasting and later onset behavioural 
and cognitive dysfunctions following mTBI were also supported by animal studies (Mychasiuk 
et al., 2015a, White et al., 2017). Therefore, the recovery trajectory after mTBI in children is 
complex and cannot be solely explained by plasticity or vulnerability. 
 
1.2.1. The effect of age on the neuronal reaction to TBI 
 
During normal ageing, the loss of neurons is initially observed in the cortex and hippocampus 
(Peters, 2002), furthermore, the size of neurons has been found to decrease with ageing, 
which suggests reduced arborization of axons and dendrites, and a subsequent reduction in 
synapses (Hof and Morrison, 2004). With the emergence of advanced imaging techniques, 
more studies suggest that there is not a substantial reduction in neurons in most brain regions 
(Egawa et al., 2016). In the context of TBI, increased lesion size and neurodegeneration in 
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the hippocampus and thalamus were observed in aged rather than young mice at 7 days after 
moderate TBI (Kumar et al., 2013).  
 
Synaptic dysfunction may contribute to the cognitive deficits in the aged. Decreased synaptic 
density in the cortex and hippocampus has been observed with aging and is associated with 
cortical dysfunction and cognitive decline (Morrison and Baxter, 2012). Additionally, synaptic 
functional changes can be attributed to reduced glutamate release, and altered postsynaptic 
structure (including dendritic spine density decrease and synaptic contact area reduction) 
(Morrison and Baxter, 2012). With ageing, pyramidal neurons have been shown to exhibit 
progressive regression in dendritic arbors in the cortex (Kabaso et al., 2009), as well as 
reduction in complexity of apical and basal dendrites has also been observed with ageing 
(Kabaso et al., 2009). Spine loss has also been found in pyramidal neurons (Cupp and 
Uemura, 1980), this is further supported by a decrease in the density of apical and basal 
dendritic spines with ageing (Kabaso et al., 2009). Dendritic and spine changes with ageing 
could potentially affect the functional properties of individual neurons, and subsequent 
cognitive and behavioural functions.  
 
In the context of TBI, the apical dendritic branches, total dendritic length, and spine density in 
the nucleus accumbens decreased after chronic moderate TBI in adolescent mice, which was 
not observed in adult mice (Cannella et al., 2019). However, at 3 months after injury, N-methyl-
d-aspartate receptor subtype 2B (NR2B) expression in the hippocampus was decreased by 
20% in both adolescent and adult mice, and there was no difference in NR2B expression in 
the cortex between injured and sham adolescent or adult mice (Mannix et al., 2017). 
 
White matter impairment has been associated with behavioural and cognitive decline 
(Farokhian et al., 2017). It has been demonstrated that there is a decrease in brain white 
matter but not in grey matter in aged patients (Joo et al., 2010). Additionally, white matter 
volume reduction in the orbitofrontal cortex and corpus callosum has been observed with 
ageing (Bartzokis et al., 2003, Hedden and Gabrieli, 2004). Reduction in myelinated axons 
and mild demyelination in the subcortical white matter has also been reported, which may 
contribute to the functional decline seen in normal ageing (Xie et al., 2016). Furthermore, a 
decrease in the number of optic nerve axons and degeneration of axons were observed with 
ageing (Stahon et al., 2016). This thicker myelin also had longer and thicker mitochondria, 
which increased oxidative stress and disrupted ionic homeostasis, increased nodal and 
paranodal distance and disrupted axonal function (Stahon et al., 2016). Additionally, axonal 
transport including mitochondrial transit has been observed to decline during ageing (Milde et 
al., 2015). Axonal regenerative capacity has also been found to decrease with ageing 
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(Roozbehi et al., 2015). Moreover, higher diffuse axonal injuries, vascular anomalies, and 
behavioural deficits have been observed in aged patients (Gattu et al., 2016).  
 
In the context of TBI, white matter area has been shown to be decreased in adult but not in 
adolescent mice compared to sham mice after rmTBI (Mannix et al., 2017). Additionally, 
axonal injury in the corpus callosum, detected by APP immunoreactivity, was greater in aged, 
as opposed to young mice, observed after acute and chronic phases after rmTBI (Ferguson 
et al., 2017b, Mouzon et al., 2018b). However, the neurofilament response in the optic tract 
was robust in young injured mice but markedly attenuated in old injured mice after mTBI 
(Cheng et al., 2018). Thus, how the brain injury interacts with age at injury is still inconclusive. 
 
Glymphatic dysfunction has been shown in animal model of TBI (Christensen et al., 2020), 
which may contribute to the build up of proteinaceous waste products, including p-tau and 
beta-amyloid in TBI patients (Jessen et al., 2015). Additionally, during ageing, glymphatic 
system function decreases dramatically (Jessen et al., 2015). Thus, the accumulated effects 
of injury and ageing may exacerbate the development of tau pathology and neuronal 
dysfunction (Iliff et al., 2014). 
 
1.2.2. The effect of age on the astrocytic reaction to TBI  
 
The phenotype of astrocytes changes between young and aged patients, from long and 
slender processes in young patients to short and stubby processes in older subjects (Jyothi 
et al., 2015). This inflammatory morphological change has also been observed in rodents, and 
was region dependent, increased in striatum but reduced in retina (Jinno, 2011). In normal 
ageing, increased astrocyte activation with exacerbated pro-inflammatory gene expression 
has been observed, which could disrupt BBB function (Wu et al., 2005, Clarke et al., 2018), 
and increase cytokine production to exacerbate the inflammatory response (Clarke et al., 
2018). Additionally, astrocyte activation could also accumulate and increase reactive oxidative 
stress (Ishii et al., 2017), and interrupt mitochondrial function (Sundar Boyalla et al., 2011). 
Astrocytes have also been suggested to interact with microglia to increase pro-inflammatory 
cytokine expression during ageing (Sierra et al., 2007).  
 
In the context of TBI, an increased astrogliosis response in the optic nerve was observed at 1 
day after rmTBI in aged compared to young mice (Tzekov et al., 2016). Additionally, reactive 
astrogliosis in the CC was observed in both young and aged mice at 15 days post injury, and 
the average percentage of area of astroglial activation for aged mice was higher compared to 
young mice for female in the CC at 15 days post-injury (Ferguson et al., 2017b). At 1 day post-
 12 
injury, the average percent area of GFAP for the injury group was greater compared to the 
sham group for female and male mice. Aged mice showed higher astrogliosis compared to 
young mice in the CC with regard to GFAP staining (Mouzon et al., 2018b).  
 
 
1.2.3. The effect of age on the microglial reaction to TBI  
 
During the ageing process, the number, location and the morphology of microglia changes, 
which may also be associated with changes in microglial function. Increased microglial 
activation has been observed during normal ageing (Grabert et al., 2016), and additionally, it 
has been observed that the population of microglia increases with ageing (Mouton et al., 
2002). In aged brains, microglia are shorter and less-branched (Hwang et al., 2008). 
Furthermore, microglia showed decreased ramified structure during ageing, which could 
potentially affect their normal function (Wong, 2013), including toxicity removal (Floden and 
Combs, 2011). In aged animals, microglia undergo a priming process, which is associated 
with higher inflammation, such as increased expression of inflammatory markers including 
major histocompatibility complex 2 (Henry et al., 2009).  
 
In the context of TBI, a stronger microgliosis response in the corpus callosum was observed 
in young compared to old mice at 1 day after rmTBI (Mouzon et al., 2018b). However, at 7 
days after injury, there were highly reactive microglial phenotypes in the injured cortex, 
hippocampus, and thalamus in aged rather than young mice after moderate TBI (Kumar et al., 
2013). Furthermore, at 15 days after mTBI, the injured mice showed a notable increase in 
Iba1 immunoreactivity in the CC, and the average percent area of Iba1 immunoreactivity was 
higher for aged compared to young males (Ferguson et al., 2017b). Even though the microglial 
activation at 2 days post-injury was not different between young and aged brain injured mice, 
significantly higher microglial activation was observed in the optic tract of aged compared to 
young brain injured mice at 7 days after repetitive brain injury (Cheng et al., 2018). When 
observed at longer timepoints (3 months), microglial reactivity in the CA1 area did not differ 
between adolescent and adult mice after rmTBI (Mannix et al., 2017). 
 
To sum up the influence of age at injury on outcomes following mTBI. The aged brain is 
characterized with brain atrophy, axonal degeneration, a higher inflammation state, and 
compromised neuronal connections. On the contrary, the young brain is still undergoing 
development and maturation, suggesting the young brain is characterized with resilience and 
plasticity. Thus, it suggests the aged brain is more susceptible than the young brain to assault 
(Pannese, 2011, Popa-Wagner et al., 2011). With regard to mTBI, however, compelling 
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studies have observed that a proportion of children with mTBI showed vulnerability with 
delayed and prolonged post-injury symptoms (Donders and Warschausky, 2007, Lichte et al., 
2015). In order to identify the influence of the age at injury on outcomes following mTBI, 
various studies have investigated the cellular responses after mTBI at different time points in 
the lifespan. However, to-date, studies have not comparatively assessed in a single species, 
the effects of mTBIs received at different timepoints across the entire lifespan. Since age plays 
a role in the response to mTBI, it is therefore necessary to fully understand the differences in 
cellular reactions across the entire lifespan. 
 
1.3. SEX AS A RISK FACTOR FOR mTBI OUTCOME 
 
Sex hormones influence multiple cellular functions including inflammation, oxidative stress, 
excitotoxicity and mitochondrial function (Demarest and McCarthy, 2015, Gunther et al., 2015, 
Villapol et al., 2017). The majority of TBI studies have been conducted in the male population, 
as they were thought to be more likely to sustain TBIs than females during their lifetime 
(Rickels et al., 2010), however, it has been recently observed that females in sex-comparable 
sports had a higher incidence of reporting concussion than males (Covassin et al., 2016). 
Additionally, it has been observed that most moderate to severe brain injuries occur in males 
and result from occupations, such as professional contact sports, construction or military 
occupations, while most mild injuries occuring in females result from domestic violence 
(Chang et al., 2014, Colantonio, 2016).  
 
Sex is one of the most controversial risks factor for TBI. Mixed and complicated outcomes 
between different sexes have been observed after brain injury. While some clinical studies 
found females have unfavorable outcomes compared to males, other patient studies did not 
find any difference in cognitive symptoms between sex (Bazarian et al., 2010, Covassin and 
Bay, 2012). In the clinic, observational studies have reported that outcomes are generally 
poorer in female patients compared to males after moderate and severe TBI (Kirkness et al., 
2004, Morrison et al., 2004). In addition to this, higher severity of acute post-injury symptoms 
has been reported in females compared to males patients (Berz et al., 2013). A worse working 
memory outcome was found in female compared to male patients at 10 weeks after mild injury 
(Hsu et al., 2015). Furthermore, even at 3 years after mTBI, higher frequency of PPCS and 
disability was observed in female compared to male patients (Styrke et al., 2013). However, 
females with mTBI have also been reported without impairments on neuropsychological 
performance, which may indicate female sex plays a protective role (Bai et al., 2019). This is 
supported by other studies that reported females have superior executive functioning, verbal 
memory and learning performance, when compared with males after acute TBI (Niemeier et 
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al., 2014) and less possibility of persisting PPCS after chronic TBI (Von Der Heide et al., 2013). 
Conflicting results also exist within experimental studies. Worse outcomes in females than 
males have also been found with regard to mTBI (Ferguson et al., 2017b), however, 
compelling experimental studies showed better behavioural outcomes (better balance and 
coordination) (Mychasiuk et al., 2016), and better cognitive functions (better performance in 
learning and in the Barnes Maze) in female than male mice (Velosky et al., 2017).  
 
The presence of neuroanatomical sex differences has been investigated in animal research. 
It has been reported that there was no differences in neocortical thickness (Stewart and Kolb, 
1988), or neuronal soma size or density in the primary visual cortex between male and female 
rats (Reid and Juraska, 1992). In contrast, a larger cortical volume was reported in male 
compared to female rats (Reid and Juraska, 1992). Additionaly, thinner cortices were reported 
in female compared to male mice (Velosky et al., 2017). In the context of TBI, less neuronal 
loss or degeneration (Armstead et al., 2016, Free et al., 2017), less BBB breakage and brain 
edema (O’Connor et al., 2006) and lower cerebral blood flood (Armstead et al., 2016) were 
reported in female compared to male animals after injury.  
 
Sex differences also exist with regard to the density of dendritic spines. It has been reported 
in experimental studies that females have less dendritic branching in the prefrontal cortex than 
males, whereas, in the agranular insular cortex, females had greater apical arbors than males 
(Kolb and Stewart, 1991). Spine density is sexually dimorphic, with male rats exhibiting greater 
spine density than females on principal cell densities, which possibly indicated more excitatory 
inputs from any number of afferent populations (Rubinow et al., 2009). In the context of TBI, 
female mice showed less reduction in dendritic complexity of pyramidal neurons in the 
ipsilateral prefrontal cortex compared to male injured mice (Semple et al., 2017). Additionally, 
it is also reported that female rats with less density of spines in the nucleus accumbens 
compared to male rats, but both experienced a significant reduction following the mTBI (Hehar 
et al., 2015).  
 
Sex differences in the diameter and g ratio (the ratio of the inner axonal diameter to the total 
outer diameter) of myelinated axons have been reported, with thicker axonal diameters and 
higher g ratios in female rats compared to in male rats (Pesaresi et al., 2015). Moreover, a 
significant sex difference in the ratio of unmyelinated to myelinated axons has been reported, 
with females having higher numbers of unmyelinated axons and a greater ratio of 
unmyelinated to myelinated axons in the corpus callosum. No differences in the size of either 
axon type or myelin thickness was observed. These results suggested that there was a sex 
difference in the proportion of axon types (Mack et al., 1995). In the context of TBI, a sex 
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dependent difference in axonal pathology has been shown, with reduced phosphorylated tau 
in the cortex and hippocampus in aged female but not in aged male injured mice (Ferguson 
et al., 2017b). This difference was not observed in young mice. Among younger mice, the 
effect of sex on white matter degeneration was similar among females and males after injury 
(Ferguson et al., 2017b).  
 
The activation of astrocytes was suggested to occur in a sex dependent manner. Under basal 
unstimulated conditions, astrocytes from male and female mice showed similar mRNA levels 
of anti and pro inflammatory cytokines (Santos-Galindo et al., 2011). However, sex differences 
in the distribution of GFAP immunoreactivity were detected in rat hippocampus and globus 
pallidus (Garcia-Segura et al., 1988). Furthermore, it was reported that the immunoreactivity 
of GFAP in CA1 and CA3 areas was significantly higher in male compared to age-matched 
female rats (Conejo et al., 2005).  
 
In the context of TBI, it is reported that injury induced astrogliosis in the peri-injury area was 
comparable between female and male rats at 1 day after brain injury (Gunther et al., 2015). 
Furthermore, another study reported GFAP mRNA levels without any sex related differences 
in the rat prefrontal cortex and hippocampal at around 17 days after final injury (Yamakawa et 
al., 2017). At 32 days after the repetitive injury, increased astrocyte reactivity in the corpus 
callosum and optic tract in the ipsilateral side was similar between female and male injured 
mice, however, in the optic tract in the contralateral side, male injured mice had significantly 
increased GFAP immunoreactivity than female injured mice (Velosky et al., 2017).  
 
Sex differences have been reported for the activation of microglia. No sex difference in glial 
density in the primary visual cortex was observed in rats under basal unstimulated conditions 
(Reid and Juraska, 1992). However, sex dependent microglia gene expression was reported, 
with major genes expressed in male mice belonging to the inflammatory process including 
regulation of cell migration and cytokine production, while most genes expressed in female 
mice were associated with inflammatory response inhibition and repair promotion (Villa et al., 
2018). Furthermore, it was also reported that microglia in male mice had increased phagocytic 
activity and higher ROS levels in the brain, whereas microglia in female mice had increased 
production of TNF-α and IL-1β (Doran et al., 2019). 
 
In the context of TBI, it was reported that there were no sex dependent differences in 
phagocytic activity in resident microglia in brain injured mice at either 1, 3 or 7 days after injury 
(Doran et al., 2019). However, male mice showed a significant influx of peripheral myeloid 
cells by 1 day post-injury followed by proliferation of resident microglia at 3 days post-injury. 
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In contrast, myeloid infiltration and microglial activation responses in female injured mice were 
significantly reduced (Doran et al., 2019). Additionally, at 17 days after the final injury, there 
was an increase in the number of Iba1 positive microglia in the ventromedial hypothalamus in 
male, but not in female rats (Yamakawa et al., 2017). 
 
In summary, sex dimorphs exist in various cellular changes, including the cortical thickness, 
spine density, axonal degeneration, and glial response. Conflicted results have been found 
with regard to how sex affects outcomes following TBI. Despite differences being identified in 
the cellular response to TBI between sexes, the results are inconclusive. 
 
1.4. REPETITION OF INJURY AS A RISK FACTOR FOR mTBI OUTCOME  
 
Contact sport (like football, boxing, ice hockey, martial arts and soccer) athletes and military 
personnel are at high risk of suffering repetitive mTBI (Gardner and Yaffe, 2015). The initial 
injury may recover within a few days or weeks, however, the effects of additional injuries could 
potentially result in long-term neurological and functional deficits (Smith et al., 2013b). Clinical 
studies found rmTBI was accompanied with prolonged depression, reduced cognitive 
performance and prolonged recovery (Ling et al., 2017, Merritt et al., 2018, Maynard et al., 
2019). Furthermore, it has also been associated with a variety of neurodegenerative disorder 
related pathologies, including pathologies in amyloid beta, tau, TAR DNA-binding protein 43 
(TDP-43), and chronic traumatic encephalopathy (Saing et al., 2012, Solomon and 
Zuckerman, 2015, Xu et al., 2016). Additionally, chronic neuroinflammation, ongoing axonal 
degeneration and white matter atrophy, cerebrovascular abnormality, depositions of abnormal 
tau and neurobehavioural impairments following rmTBI were also observed in animal studies 
(Mouzon et al., 2014, Petraglia et al., 2014, Ojo et al., 2016). In order to understand the 
pathology of rmTBI, numerous animal models have been used to model the changes after 
injury. Studies using these models have been associated with inconsistent pathological and 
functional findings, which may be partly attributed to the variable number of injuries and 
intervals between them (Meehan III et al., 2012). Various injury parameters, including number 
of injuries and interval between injuries, were applied to model rmTBI, with some suggesting 
shorter interval between injuries was associated with exacerbated pathology (Weil et al., 2014, 
Gold et al., 2018), while other suggesting the interval between injuries do not affect long-term 
pathological and behavioural outcomes (Fujita et al., 2012, Hall et al., 2016).  
 
Studies modeling repetitive mild injuries on neuronal changes report inconsistent outcomes. 
There are studies reporting no overt neuronal death or cortical damage after repetitive injury. 
Boltman and colleagues report no significant neuronal degeneration in the entorhinal cortex 
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at 9 days following 5 injuries at 2 day intervals (Bolton and Saatman, 2014). At 14 days after 
injury, it has been observed that there was no overt structural change or neuronal loss after 4 
injuries at 7 day intervals (Xu et al., 2016). Furthermore, at later time points, no overt structural 
changes or neuronal loss has been observed at 40 days after 2 injuries at 3 day apart (Weil 
et al., 2014). Moreover, no neuronal loss in the injured cortex following 5 injuries at 2 day 
intervals has been observed at 2 months after injury (Gold et al., 2018). It has been reported 
that the second mild injury delivered at a 1 day interval did not cause cell death in the cortex 
7 days after the initial injury (Shitaka et al., 2011). However, 10 injuries at 1 day intervals 
significantly decreased the number of neurons in the injured cortex at 2 months after injury 
(Gold et al., 2018).  
 
Diffuse axonal injury is considered to be a key feature of mTBI pathology (Bigler, 2013). 
Studies modeling repetitive mild injuries on axonal changes found higher axonal damage after 
repeat brain injuries. After acute brain injury, there was increased axonal injury in the external 
capsule, at 5 days after 5 injuries at 1 day intervals and 9 days after 5 injuries at 2 day intervals 
(Bolton and Saatman, 2014). At 7 days after brain injury, increased APP was observed in the 
cortex, corpus callosum, and external capsule after 2 injuries at 1 day intervals (Shitaka et al., 
2011). In this study, dystrophic myelinated axons, axoplasmic collapses, and cytoskeletal 
disruptions were also observed (Shitaka et al., 2011). At 14 days after brain injury, higher 
axonal degeneration in the corpus callosum was observed after 4 injuries at 1 day intervals 
(Hylin et al., 2013), and additionally, increased axonal degeneration profiles were also 
reported in the corpus callosum at 14 days after 4 brain injuries at 7 day intervals (Xu et al., 
2016). At 40 days after brain injury, axonal degeneration was significant and widespread. It 
was particularly pronounced in the corpus callosum, caudate putamen and dentate gyrus after 
2 injuries at 3 day intervals but not at 20 day intervals (Weil et al., 2014). After chronic brain 
injury, white matter abnormalities and corpus callosum atrophy developed at 2 and 6 months 
after 5 injuries at 2 day intervals and 10 injuries at 2 day intervals, respectively (Gold et al., 
2018). Furthermore, at 6 months and 12 months after brain injury, the average thickness, as 
well as increased APP immunoreactivity of the corpus callosum was reduced after 5 injuries 
at 2 day intervals (Mouzon et al., 2014). Furthermore, increased silver staining in the external 
capsule was observed at 8 days and 22 days after 2 brain injuries at 1 day intervals, but not 
at 92 days post-injury (Fidan et al., 2016). In summary, increased axonal pathological changes 
have been widely observed at both short-term and long-term timepoints after repetitive 
injuries. 
 
Understanding of microglia changes after repetitive mild injuries is incomplete. After acute 
injury, at 5 days after injury, there was no differences in microgliosis in the hippocampus but 
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it was higher in the entorhinal cortex following 5 injuries at 1 day intervals (Bolton and 
Saatman, 2014). At 7 days post-injury, there was higher microglial activation in the ipsilateral 
cortex, hippocampus, and thalamus, and corpus callosum following 2 injuries at 1 day intervals 
(Shitaka et al., 2011). However, at 8 days after injury, there was no significant microglial 
activation in cortex, hippocampus or amygdala after 2 injuries at 1 day intervals (Fidan et al., 
2016). At 14 days post-injury, higher microgliosis was found in the corpus callosum after 4 
injuries at 1 day intervals (Hylin et al., 2013). At 40 days post injury, microglial activation was 
evident in the sensorimotor cortex, hippocampus, and thalamus after 2 injuries at 3 day 
intervals (Weil et al., 2014). At 12 months after chronic injury, there was no differences in 
microglial activation in the cortex or corpus callosum after 5 injuries at 2 day intervals (Mouzon 
et al., 2014).  
 
Similarly, studies on astrocyte response after repetitive mild injuries are mixed. After acute 
injury, there was no differences in astrocytosis in the entorhinal cortex, but it was higher in the 
hippocampus at 5 days following 5 injuries at 1 day intervals, and at 9 days following 5 injuries 
at 2 day intervals (Bolton and Saatman, 2014). Additionally, higher astrogliosis in the corpus 
callosum at 14 days after 4 injuries at 1 day intervals was observed (Hylin et al., 2013). 
Moreover, evidence of astrocytic activation was observed in the sensorimotor cortex, 
hippocampus, and thalamus at 40 days after 2 injuries at 3 day intervals (Weil et al., 2014). 
After chronic injury, there was also higher astrogliosis in the somatosensory cortex at 12 
months after 5 injuries at 2 day intervals (Mouzon et al., 2014). Thus, increased astrocyte 
activation has been reported at longer timepoints after repetitive injuries. 
 
Although a number of animal studies modeling rmTB have been performed, complex and 
conflicting cellular and subcellular responses have been found, which may be partially 
attributed to the various number of injuries and injury time intervals used. Therefore, more 
animal studies on how the number of injuries and time intervals influence mTBI outcomes are 
needed. 
 
The Controlled Cortical Injury (CCI), Weight Drop Injury, Blast Injury and Fluid Percussion 
Injury (FPI) models have all been used to replicate aspects of mTBI, each having their own 
strengthens and weaknesses. The CCI and FPI models have the best characterization over 
varied injury levels. These two models also lend themselves more easily to repetitive injury 
paradigms, which may also be particularly important when studying mTBI (Laurer et al., 2001, 
Kane et al., 2012, Wang et al., 2012). CCI is a well-characterized model of focal TBI. The 
major disadvantage of CCI models is the need to perform craniotomies, which in itself disrupts 
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the normal parenchyma, activates immune cells/microglia, and can trigger of gliosis in the 
brain (Lagraoui et al., 2015). 
 
The fluid percussion injury can be used to deliver both midline and lateral fluid percussion 
injuries (Dixon et al., 1987, McIntosh et al., 1987, Lyeth et al., 1990). This model is widely 
used as it mimics clinical contusion without skull fracture (Cernak, 2005). The advantages of 
the fluid percussion model include that it is a widely used model with well-defined pathology 
and both the neurobehavioural deficits (Hameed et al., 2014). The main disadvantages in this 
model are concerns associated with the need for both craniectomy(Floyd et al., 2002), and 
anaesthesia (Silva et al., 2011, Bowles and Gold, 2012). According to Thompson, the lateral 
FPI model has emerged as the model most applicable to concussion and mTBI (Thompson et 
al., 2005, Lifshitz et al., 2007), additionally, fluid percussion can induce mild brain injury in 
mice of various ages (Shah et al., 2006, Titus et al., 2013, Zhang et al., 2013). 
 
1.5. THESIS AIMS 
 
There are many risk factors for mTBI, including the age at injury, sex, number of injuries and 
interval between injuries, however, details on how these factors affect the outcomes after 
mTBI are still inconclusive with many issues still to be resolved.  
 
Whether the young are resilient or vulnerable to mTBI, if females are more or less vulnerable 
than males to mTBI, and whether a short time interval between injuries and additional injuries 
exacerbate mTBI pathology, are not fully understood. Animal models allow precise control of 
confounding factors including genetics, injury type and comorbidities. Therefore, the primary 
objective of this thesis is to further investigate the influence of the age at injury, sex and 
number of injuries and interval between them, on the cellular and subcellular responses after 
mTBI in a mouse model. A complimentary study seeks to the use a potentially multi target 
drug intervention to improve outcomes after mTBI. The current thesis is based on the 
hypotheses that the cellular and subcellular responses (including neuronal and glial changes) 
vary greatly depending on other risk factors, supporting the rationale for a more personalized 
medicine approach for the treatment of mTBI.  
 
Aim 1: To discover the similarities and differences in cellular responses following mTBI 
in the young, adult and aged brains 
 
Investigating the interplay between age at injury and mTBI is vital for understanding the 
vulnerability of different ages to mTBI and for suggesting the potential age dependent therapy. 
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To date, cellular changes following mTBI in a single species across the lifespan have been 
less well studied. Using immunohistochemical techniques Chapter 3 of this thesis aimed to 
investigate the similar and differential cellular response following mTBI in a Thy1-YFPH mice 
model. 
 
Aim 2: To determine the therapeutic potential of the microtubule stabilizing agent 
epothilone D following mTBI in young and adult mice 
 
Microtubule stabilizing agents have been proposed as potential treatment for TBI, spinal cord 
injury and neurodegenerative disease, in which epothilone D may be able to protect axons 
and dendrites, and inhibit the glial response. Dysregulation of neuronal microtubules after 
mTBI supports the potential treatment with microtubule stabilizing drugs. In Chapter 4 of this 
thesis, a low dose of microtubule stabilization drug epothilone D was administered in young 
and adult mice following mTBI in order to understand the therapeutic potential of epothilone 
D in different ages after brain injury. 
 
Aim 3: To investigate the cellular changes following mTBI in male and female mice  
 
It is still controversial as to whether males or females have better outcomes following mTBI in 
both animal and patient studies. Furthermore, females TBIs are less-studied compared to 
males. Chapter 5 of this thesis aimed to identify the similar and different cellular and 
subcellular responses after mTBI in both male and female Thy1-YFPH mice. 
 
Aim 4: To investigate the cellular changes following an additional mTBI in a mouse 
model 
 
There are increasing numbers of repetitive brain injuries across the world especially among 
children and adults involved in contact sports. However, cellular changes in animal studies 
modeling rmTBI are still inconclusive - while some found the number of injuries exacerbated 
the pathology, others did not. Chapter 5 of this thesis aimed to investigate the cellular changes 




2. MATERIALS AND METHODS 
 
2.1. BREEDING AND GENOTYPING OF THY1-YFPH TRANSGENIC MICE  
 
All experiments were approved by the Animal Ethics Committee of the University of Tasmania 
(ethics approval number A0015573) and were performed in accordance with NHMRC 
Australian Code of Practice for the Care and Use of Animals for Scientific Purposes 2013. 
Studies were performed on young (1.5 months), adult (3 months) or aged (12 months) Thy1-
YFPH transgenic mice. B6.Cg-Tg(Thy1-YFP-H)16Jrs/J (Stock #003782) mice were 
purchased from The Jackson Laboratory and maintained on a C57BL6 background. In these 
animals yellow fluorescent protein (YFP) is expressed under the control of the neuron-specific 
Thy1 promoter in approximately 80% of layer 5 and 2/3 neocortical pyramidal neurons (Fig 
2.1) (Feng et al., 2000, Porrero et al., 2010). Ear punches were taken at weaning (4 weeks) 
to determine inheritance of the YFP transgene. Mice were housed in standard conditions 
(20℃, 12h/12h light/dark cycle), with access to food and water at libitum. 
 
2.2. SURGERY PREPARATION  
 
All surgical procedures were performed in a bio BUBBLE (FortCollinsco. CO, USA) with 80–
100 HEPA filtered air circulations per hour. Mice were transferred to the surgical room, 
acclimatized for 30 min and weighed. The surgical bench and microscope was wiped down 
with isopropanol alcohol (IsowipeR, Kimberly-Clark, Australia). All surgical instruments were 
autoclaved. Mice were randomized to the injury group and sham group. All mice underwent 
identical surgery procedures. Briefly, mice were anesthetized in a plexiglass chamber with 5% 
isofluorane (Isoflo, Abbot Australasia Pty Ltd, Botany, NSW, Australia) in 100% oxygen. The 
head was secured in a stereotaxic frame (Narishige, Tokyo, Japan), with the body positioned 
on a warming pad (Stoelting, Wood Dale, IL, USA) to maintain body temperature during 
surgery. Once secured in the stereotaxic frame, surgical plane anesthesia (1.5-2% in oxygen) 
was maintained via nose cone and viscotears (Kingston-upon-Thames, Surrey, UK) was 
administered to the eyes. The scalp was cleaned with betadine (Sanofi-aventis Consumer 
Healthcare, Virginia, QLD, Australia) and 70% ethanol, and the topical anaesthetic bupivicaine 
(Bupivicaine hydrochloride, 50ul 0.25% in sterile saline; Pfizer, West Ryde, NSW, Australia) 
was administered under the scalp. A midline incision was made to expose the skull and a 3.0 
mm craniotomy was made on the right parietal bone halfway between the sutural landmarks 
lambda and bregma. An injury hub was created by cutting off the metal end of a 22G needle 
(Livingstone international Pty Ltd, Rosebery, NSW, Australia) with a razor blade. The hub was 
attached to the skull with adhesive Loctite 454 (Henkel Australia, Sydney, NSW, Australia) 
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and dental cement (Heraeus Dental Science, Villebon, France) and was then filled with sterile 
saline. Pre-, peri- and post-surgical monitoring were performed to determine respiratory rate, 
confirm absence of reflexes and monitor mucous membranes/capillary refill time. Following 
application of the injury hub, mice were left to recover for one hour prior to application of the 
injury pulse. 
 
2.3. LATERAL FLUID PERCUSSION BRAIN INJURY (LFPI)  
 
In preparation for LFPI, each mouse was re-anesthetised in a pre-charged induction chamber 
containing 5% isoflurane in 100% oxygen. Following induction of anaesthesia, the animal was 
removed from the induction chamber, the hub was re-filled with sterile saline and attached to 
the FP302 Fluid Percussion Device (AmScien Instruments, Richmond, VA, USA; see Fig 2.2) 
via a 10cm spacing tube filled with sterile Milli-Q water. Briefly, a pendulum is released from 
a predetermined height, striking a piston connected to a chamber filled with saline solution, 
which generates a fluid pressure pulse against the intact dura. The mouse was placed on a 
heated pad and once a normal pattern of breathing resumed, but prior sensitivity to stimulation, 
an injury of mild severity was delivered to the intact dura by releasing the device’s pendulum 
onto a fluid filled piston, causing transient displacement and deformation of the dura and 
underlying brain. A transducer incorporated into the device measured the pulse pressure and 
the peak pressure was recorded within the software. Following injury, mice were placed on 
their back and visually monitored for recovery of spontaneous breathing. Additionally, the time 
taken for animals to recover the righting reflex was recorded as a measure of transient 
unconsciousness/loss of consciousness (LOC). sham-operated mice underwent identical 
surgical procedures to brain injured mice and were connected to the injury device, however 
the pendulum was not released. Following injury/sham-operation, mice were re-anesthetized, 
the injury hub was removed and the incision sutured. Mice were observed for 2 hours (hrs) 
prior to return to their home cages and provided free access to food and water. For the first 
week following LFPI or sham-operation, animals were scored daily for signs of illness and 
stress and once a week thereafter.  
 
2.4. IMMUNOHISTOCHEMISTRY AND STAINING OF MOUSE BRAIN TISSUE SECTIONS 
 
All animals were deeply anesthetised with an overdose of sodium pentobarbital (300mg/kg; 
Troy Laboratories Pty Ltd, Smithfield, NSW, AU) and perfused transcardially with a fixative 
containing 4% paraformaldehyde (PFA) in 0.01M phosphate-buffered saline (PBS). The brains 
were removed and post-fixed in PFA overnight and then stored at 4℃ in 0.01M PBS containing 
0.02% w/v sodium azide (Sigma Aldrich,Castle Hill, NSW, AU). Following overnight fixation, 
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the brains were embedded in 5% agarose and coronal sections with a thickness of 50 μm 
were generated using Leica VT1000S vibratome (Biosystems Australia Pty Ltd, Mount 
Waverly, VIC, AU). For immunohistochemistry, sections representing the impact site were 
placed serially into individual wells of a 24-well culture plate and processed as free floating 
sections. Sections were washed three times in 0.01M PBS then incubated in a solution of 
primary antibody diluted in the permeabilizing agent (0.03% Triton X-100) at room temperature 
for a period of 1 hr, and then transferred to 4℃ room for a period of 12 hrs. Primary antibodies 
included a rabbit anti-GFAP antibody (Z0334, 1:2000; Dako) or a rabbit anti-Iba-1 antibody 
(019-19741, 1:1000; Wako) to label astrocytes and microglia, respectively. After another three 
washes in PBS, the sections were incubated with Alexa Fluor® 568 donkey anti-rabbit 
conjugated secondary antibodies (A10042, 1:1000, Invitrogen) and 4’, 6-diamidino-2-
phenylindole (DAPI) (D3571, 1:6000, Invitrogen) in PBS at room temperature for 2 hrs. The 
reactions were completed by washing with PBS three times. Following completion of the 
immunohistochemistry protocol, sections were serially mounted onto slides for analysis. 
 
2.5. MICROSCOPY AND IMAGE ANALYSIS 
 
Images were collected with an UltraVIEW spinning disk confocal microscope running Volocity 
Software (PerkinElmer Australia Pty Ltd, Glen Waverley, VIC, AU), equipped with a 20x/0.5 
air and Plan Apo 60x/1.20 water objective (Nikon, New York, NY). In order to get the same 
brain section of each mouse across groups, another investigator was appointed to choose the 
section where the two blades of the hippocampal dentate gyrus were clearly visible with DAPI 
staining. When performing the data analysis, I was blinded to all the animals. For quantitation 
of cortical thickness and YFP positive cell number and size, the microscope was configured 
to capture large stitched images of upper hemispheric quadrant of each brain with 20x 
objective (20um z-stacks, 1um slices). Quantification was performed in the entire upper 
ipsilateral quadrant of the neocortex (area outlined in red, Fig 2.1). For quantification of cortical 
thickness, three straight lines were manually drawn across images of the neocortex; one on 
the top end, one at the middle, and one on the bottom end. These measurements were 
averaged to get the overall cortical thickness. For quantification of YFP positive cell number 
and size, soma falling within this region were manually traced to determine average somal 
size as well as the number of soma per area of neocortex, or cell density of YFP positive 
neurons.  
 
For quantification of astrocytic and microglial activation (the percentage of area occupied by 
GFAP expressing astrocytes and Iba-1 expressing microglia, respectively), the microscope 
was configured to capture large stitched images of the neocortical region of the injury site of 
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each brain with 20x objective (20um z-stacks, 1um slices). The neocortical impact site was 
manually traced in ImageJ (area outlined in yellow, Fig 2.1), and was converted to an 8-bit 
image. A threshold was applied to capture all staining and the percentage area of GFAP or 
Iba1 positive cells in the injured cortex was determined. Furthermore, in the current study, 
similar to other investigations, a counterstain hasn't been applied either for the imaging or 
analysis (Wang et al., 2018, Broussard et al., 2018). However, applying a nuclear counterstain 
for the analysis, such as DAPI, would have allowed a further assessment of number of 
microglia relative to all cells (Liu et al., 2018), in addition to the measures of ‘number of cells’ 
and ‘percentage area of immunoreactivity’ as reported. 
 
Axon vulnerability was investigated within the Internal Capsule (IC), which is a large axonal 
tract directly under the pressure wave that is elicited in the LFPI model (outlined in blue, Fig 
2.1). Axonal degeneration was quantified as the amount of axonal degeneration, the relative 
number of axonal fragments and the size of the axonal fragments in YFP positive axons. First, 
large stitched images of the internal capsule were captured with 20x objectives (20um z-
stacks, 1um slices). The internal capsule was traced in ImageJ according to the mouse brain 
map (area outlined in blue, Fig 2.1), and was converted to 8 bit, and then was threshold to 
end of pixels. After seting the partical analysis (size from 10-10000, circularity from 0.3-10), 
the data of the percentage of area, the number of the particals and the average size of the 
particles were measured.  
 
For dendritic spine density analysis, image stacks were captured with the 60x water objective 
(20um z-stacks, 0.2um slices) from layer 5 of the injured cortex. In Neurolucida (MBF 
Bioscienes, Willoston, VT, United States), dendrite and spine analysis was performed in 
Neurolucida. Dendritic shafts were traced from image stacks and spines were manually added 
onto the traced dendrites and categorized into mushroom (prominent head, thin neck), stubby 
(greater width than length), and thin (greater length than width) spines. Changes in dendritic 
spine density were determined by loading Neurolucida data files into Neurolucida ExplorerTM 
(MBF Biosciences). 
 
2.6. STATISTICAL ANALYSIS 
 
All data was analyzed and graphs were created in GraphPad Prism (version 8.0, La Jolla, CA, 
United States), and all the data sets were first analyzed by normality tests (results in Appendix, 
page 124). If a data set fails the normality test, the logarithm or square root transformation 
were used to make the data normal distribution (de Carvalho et al., 2007). Then t tests or one-
, two-, or three way analysis of variance (ANOVA) was used followed by Tukey’s multiple 
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comparison test. Results were expressed as the mean ± standard error of the mean. In all 
cases, a p-value of <0.05 was considered significant. Statistically significant differences are 
noted on graphs where present. As it is not possible to perform a power calculation prior to 
commencing a largely exploratory hypothesis, n=6 animals was selected due to previous 
publications which found statistically significant results with similar numbers in similar 
experimental conditions (Zhu et al., 2003, Cutler et al., 2007, Suenaga et al., 2015, Ritzel et 
al., 2019). All figures were prepared in Adobe Photoshop CC (version 17.0.0, Adobe Systems, 




Figure 2.1. The coronal section of the Thy1-YFPH transgenic mouse brain. 
 
Representative image of a coronal section of the Thy1-YPFH transgenic mouse brain. The 
area encompassed by the red line represents the area used for cortical thickness, somal 
size and cell density analysis. The area covered by yellow line represents the area used for 
the percentage area of glia analysis. Additionally, the area covered by blue box represents 
the area used for microglial morphology analysis. And the area covered by blue line 





















Figure 2.2 Lateral fluid percussion injury (Adapted from Lippert-Grüner et al., 2007) 
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mTBI, accounting for more than 80% of TBI cases (Luo et al., 2017, Dewan et al., 2018), is a 
serious public health issue with roughly 42 million people affected worldwide each year 
(Gardner and Yaffe, 2015). Clinically, mTBI is often caused by an impact or blast exposure to 
the head and may result in a brief alteration in consciousness or post-traumatic amnesia 
lasting less than 24h, loss of consciousness lasting less than 30 min, and a Glasgow Coma 
Score between 13 and 15 (Yu et al., 2017). With a growing ageing population, the number of 
aged mTBI cases is increasing. Previous studies have suggested that increased age at the 
time of injury is associated with higher mortality and morbidity, as well as worse behavioural 
and cognitive impairments. However, the underlying pathophysiological mechanisms which 
contribute to worse outcomes after TBI with ageing are less well studied and remain poorly 
understood.  
 
The cellular responses are vital to the pathological and functional changes after TBI. Animal 
studies have shown mTBI is not associated with overt cortical loss. Overwhelming evidence 
however indicates that one of the major pathological features of mTBI is widespread axonal 
disruption, particularly in the white matter tracts (Sword et al., 2013, Hånell et al., 2015, Katz 
et al., 2015, Mierzwa et al., 2015, Sinha et al., 2017, Vascak et al., 2018). Experimental studies 
have also shown that subtle axonal damage manifests acutely following injury, with the 
potential to progress over subsequent years (Johnson et al., 2013a, Johnson et al., 2013b). 
Furthermore, results from both clinical and experimental studies have found glial activation 
during acute, subacute and chronic phases following brain injury, which may have both 
beneficial and detrimental implications for the axonal damage and recovery (Kou and 
VandeVord, 2014). Despite achieving a greater understanding of the vulnerability of the brain 
to diffuse axonal damage and glial activation in mTBI, it remains unclear how age at the time 
of injury affects axonal pathology and glial reactions following mTBI and the sequence of 
events that lead to the lasting axonal and glial changes. 
 
The ageing brain is characterized by a number of different properties, including brain atrophy, 
decreased brain plasticity, higher oxidative stress, metabolism disruption, and a pro-
inflammatory state (Craft, 2005, Yankner et al., 2008, Romano et al., 2010, Pannese, 2011, 
Popa-Wagner et al., 2011, Petralia et al., 2014, Seib and Martin-Villalba, 2015). Clinical and 
experimental studies suggest that outcomes following TBI worsen with age (Durham et al., 
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2000, Thompson et al., 2006, Onyszchuk et al., 2008, Rowe et al., 2016, Yamagami et al., 
2019). With regard to young animals, the brain is still undergoing development and typically 
displays relatively high levels plasticity. Furthermore, abundant neural stem cells, quicker 
amyloid beta debris clearance, and quicker metabolism recovery in young animal brains have 
been observed (Venkitaramani et al., 2007, Deng-Bryant et al., 2011, Zhang et al., 2017b). 
However, clinical studies have demonstrated that the immature brain may actually be more 
vulnerable, rather than resilient, to brain injury (Kirkwood et al., 2006, Donders and 
Warschausky, 2007, Lichte et al., 2015, Keenan et al., 2018, Karr et al., 2019). Thus, it is still 
inconclusive how age at the time of injury influences recovery from mTBI. Although many 
animal studies have reported the sequela of mTBI at distinct time-points in the lifespan (Sword 
et al., 2013, Kou and VandeVord, 2014, Hånell et al., 2015, Mierzwa et al., 2015, Vascak et 
al., 2018), few have investigated the cellular response to a mTBI received at critical points 
throughout the lifespan in a single species, using a consistent animal model. To address this 
gap, we used the mild lateral fluid percussion brain injury model to determine the evolution of 
cellular pathology at critical points across the lifespan in a mouse model. 
 
3.2. MATERIALS AND METHODS 
 
Studies were performed on young (1.5 months), adult (3 months) and aged (12 months) Thy1-
YFPH transgenic male mice. Mice were randomized to the injury group (n=6 young FPI 1wk, 
n=6 young FPI 4wk, n=6 adult FPI 1wk, n=6 adult FPI 4wk, n=5 aged FPI 1wk, and n=6 aged 
FPI 4wk), sham group (n=5 young sham 1wk, n=6 young sham 1wk, n=6 adult sham 1wk, n=6 
sham 4wk, n=6 aged sham 1wk, and n=6 aged sham 4wk) and naïve group (non-injured, n=6 
young, n=5 adult, and n=6 aged) groups. Lateral fluid percussion injury (LFPI) of mild severity 
(1.40±0.01 atmospheres) was delivered to the intact dura by releasing device’s pendulum onto 
a fluid filled piston, causing transient displacement and deformation of the dura and underlying 
brain. Finally, mice were perfused at either 1 week or 4 weeks post injury. Naïve mice were 
perfused at 1.5 and 3 months and 12 months of age to match their young, adult and aged 
brain-injured and sham-operated counterparts. Details regarding immunohistochemistry 
protocols, imaging and analysis can be found in Chapter 2. Iba-1 was chosen as it is a 
traditional, well-defined marker and has been widely used to label microglia/macrophages 
(Imai et al., 1996). Additionally, Iba-1 labelling has been used to perform further analysis of 
changes in microglial morphologies in response to trauma and disease, specifically to 
investigate microglial activation (Hovens et al., 2014, Heindl et al., 2018). 
 
For quantification of microglial morphology, image stacks were captured with a 40x objective 
(1um slices; 20 slices, flattened to a single z-stack image for analysis) at the impact site (Fig 
 29 
2.1). One 40x image was taken in a section in each animal, in total there were n=72 images 
for analysis. Using an analysis protocol based on the work of Rusconi and colleagues, a 
threshold was applied to captured images (n= 72) such that the individual branches of the 
microglia could be clearly identified. Microglial activation was determined by scoring every 
microglia in the 40x z-stack as either ‘resting’ (cells with small, round cell bodies and 
elongated, thin processes) or ‘activated’ (cells with bigger, less circular cell bodies and dense 
ramifications of variable thickness; or cells with big, irregular cell bodies and only a few, 
shorter, and poorly ramified processes; or cells with an ovoid‐shaped body devoid of 
extensions or with one or two thick, unramified processes) (Rusconi et al., 2018). The 
characterization into these categories was consistently applied, and all images were blinded 
for analysis. In order to use consistently the same brain sections for analysis across groups, 
another investigator was appointed to choose the section where the two blades of the 
hippocampal dentate gyrus were clearly visible with DAPI staining. The specific site or region 
of interest directly at the center of the injury site, as could be seen in Fig 2.1 labelled with blue 
box (the injury area could be clearly identified under microscope, as the trace of craniotomy 
window above the neocortex surface could be observed), was consistently selected for image 
analysis (n=1 per section/animal, 6 animals per groups, 72 images in total analyzed). The 
investigator was blinded to the injury status of all animals. Microglia were classified as either 
‘resting’ or ‘activated’ in order to further understand the glial response to trauma. Statistically 








3.3.1. Ageing is associated with thinning of the neocortex, increased glial activation 
and axonal degeneration  
 
In the present study, cortical thickness was reduced in non-injured aged brains relative to non-
injured young and adult brains (Fig 2.1 A). In the neocortex, YFP positive cell density and 
soma size were increased in aged brains compared to young and adult brains (Fig 2.1 B, C; 
p=0.0011 and p=0.0060, respectively). Astrocyte activation was higher in aged mice relative 
to young and adult mice (Fig 2.1 F; p=0.0087). Additionally, microglial activation was increased 
in aged mice compared to young and adult mice (Fig 2.1 G; p=0.0011 and p=0.0003, 
respectively). In the internal capsule white matter tracts, axonal degeneration was higher in 
the aged compared to young and adult brains (Fig 2.1 H; p=0.0004,  p<0.0001, respectively). 
Furthermore, the relative number of axonal fragments was found to be higher in the aged 
compared to young and adult brains (Fig 2.1 I; p=0.0261, p=0.0044, respectively). The size of 
the axonal fragments was higher in the aged compared to young and adult brains (Fig 2.1 J; 
p=0.0325, p=0.0061, respectively). Total spines density and density of individual spine sub-
classes (thin, stubby and mushroom) did not differ in the cortex of aged mice compared to 
either young or adult mice (Fig 2.1 K-N; p=0.2273, p=0.0512, p=0.2348, p=0.7103, 
respectively). Overall, the aged animals were characterized as having a thinner neocortex, as 





Figure 3.1. Ageing is associated with increased glial activation and axonal 
degeneration. 
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The cortical thickness of aged (12 months) animals was reduced compared to both young 
(1.5 months) and adult (3 months) animals (A). YPF positive cell density (B) and cell soma 
size (C) was higher in the aged animals compared to young animals. Representative image 
of aged (12 months) GFAP (D) and Iba1 (E). Both the astrocytic activation (F) and microglial 
activation (G) were higher in the aged compared to young and adult animals. The 
percentage area of axonal degeneration (H), the fragmentation number (I), and the average 
size of axonal fragmentation (J) were higher in the aged animals compared to both the 
young and adult cohorts. The total spine density and the spine sub-class density did not 
differ between different age groups (K-N). Data are presented as mean ± SEM. One-way 




3.3.2. LFPI model generated a reproducible mTBI in the young, adult and aged mouse 
cohorts 
 
mTBI in the mouse is considered as a mortality rate of 0-5%, a righting reflex of 2-4min, and 
a loss of consciousness of ~2min (Morehead et al., 1994, Alder et al., 2011). In the current 
study, no mortalities were observed, however, LFPI was immediately followed by a short 
period of apnoea independent of age at injury (Fig 3.2 B; p=0.5720), and a delay of righting 
reflex time compared to sham-operated controls (Fig 3.2 C; F1,63 =151.5; p<0.0001) 
independent of age at injury (Fig 3.2 C; F2,63 =1.200; p=0.3079). Gross morphological analysis 
indicated there was no overt cortical loss or cavitation after injury, furthermore, quantitative 
analysis showed the injury did not change the cortical thickness (Fig 3.2 D; F1,61 =0.0958, 
p=0.7580), the YFP positive cell density (Fig 3.2 E; F1,61 =1.352; p=0.2494) or the soma size 
(Fig 3.2 F; F1,62 =1.116, p=0.2948) compared to the sham-operated controls at either 1 week 
or 4 weeks post injury in the 1.5, 3 and 12 month old mice. Overall, the LFPI represented mild 





Figure 3.2 LFPI model generated a reproducible mTBI in young, adult and aged mice. 
 
Representative image of LFPI in an adult Thy1-YFPH mouse brain (A). LFPI caused a short 
period of apnoea in young, adult and aged mice, with no difference between ages (B), one-
way ANOVA. The injury caused significantly increased righting reflex time in young, adult 
and aged mice, and there was no difference between ages (C), two-way ANOVA. The injury 
did not cause obvious change in the cortical thickness (D), YFP positive cell density (E) or 
cell soma size (F) across the lifespan, three-way ANOVA. Data are presented as mean ± 
SEM. ****p<0.0001. Scale bar=200um. 
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3.3.3. Astrocytic GFAP upregulation in the cortex after mTBI peaks in mice at 1.5 
months of age 
 
The consequence of mTBI on GFAP immunoreactivity was investigated within the neocortical 
region of the injury site (experimental details can be found in Chapter 2) (Fig 3.3 A). The 
percentage of area covered by GFAP immunoreactivity was investigated over the timecourse. 
An ordinary three-way ANOVA revealed a significant injury by week post injury interaction 
(F1,59 =32.91, p<0.0001). Tukey’s multiple comparisons tests identified that percentage of 
GFAP immunoreactivity was significantly increased at 1 week FPI in comparison to 1 week 
sham in animals of 1.5 months old at the time of injury (Fig 3.3 B; p=0.0039). However, this 
activation was not observed in either 3 or 12 month cohort. Furthermore, the GFAP 
immunoreactivity in injured brains was significantly resolved from 1 week post injury to 4 
weeks post injury in animals 1.5 month (p=0.0497) and 12 months (p=0.0473) of age at injury. 
Overall, this data indicates that the astrocytic response to mild injury occurs early and is 











Figure 3.3. Astrocytic GFAP upregulation in the cortex peaks at 1 week following 
mTBI in 1.5 month old animals. 
 
Representative images of astrocyte activation in sham and FPI mice, within the neocortical 
region of the injury site (A). The percentage of GFAP immunoreactivity was significantly 
increased at 1 week FPI in comparison to 1 week sham in 1.5 months of age animals. 
Additionally, the percentage of GFAP immunoreactivity at 1 week FPI was significantly 
decreased compared to 4 week FPI in animals at both 1.5 months and 12 months of age (B). 
Data are presented as mean ± SEM. Three-way ANOVA, followed by Turkey’s multiple 
comparisons tests *p<0.05, **p<0.01. Scale bar=50um.  
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3.3.4. Microglial Iba1 upregulation in the cortex is dependent on age at injury and time 
following mTBI 
 
The consequence of mTBI on Iba1 immunoreactivity was investigated within the same region 
of analysis as GFAP (experimental details can be found in Chapter 2) (Fig 3.4 A). Iba-1 is 
expressed not only in activated microglia but also in resting microglia and in circulating 
macrophages in the brain (Walker and Lue, 2015). Therefore, Iba-1 expression is expected to 
be found in both sham operated mice and brain injured mice, albeit at lower levels, as evident 
in Fig 3.4 A. The percentage of area covered by Iba1 immunoreactivity was investigated over 
the timecourse. An ordinary three-way ANOVA revealed a significant injury by week post injury 
interaction (F1,59 =60.95, p<0.0001). Tukey’s multiple comparisons tests identified that 
percentage of Iba1 immunoreactivity was significantly increased at 1 week FPI in comparison 
to both 1 week and 4 week sham in animal of 3 months old at the time of injury (Fig 3.4 B; 
p=0.0011, p<0.0001 respectively). Iba1 immunoreactivity was significantly (p<0.0001) 
increased in the 12 month cohort at both time points post injury in comparison to animals 
injured at 1.5 months (1 week sham p<0.0001, 1 week FP1 p<0.0001, 4 week sham p=0.0001, 
4 week FPI p<0.0001) (Fig 3.4 B). To determine if this alteration in microglia Iba1 
immunoreactivity was specific to a certain subtype of microglia, the number of resting and 
activated microglia were scored (Fig 3.4 C). For the resting phenotype, an ordinary three-way 
ANOVA determined that there was a significant age and injury interaction (Fig 3.4 D; F2,51 
=5.057, p=0.0059). Tukey’s multiple comparison test determined that there was a significant 
decrease in resting microglia in 12 months of age, 1-week post-injury, in comparison to 3-
month old’s (p=0.0012) and in 12 months old’s, 4 weeks post-injury in comparison to 1.5-
month old’s (p=0.0201). For the activated phenotype, an ordinary three-way ANOVA 
determined that there was a significant age and injury and time interaction (Fig 3.4 E; F2,67 
=45.57, p<0.0001). Tukey’s multiple comparison test determined that there was a significant 
increase in activated microglia at 12 months of age, 1 week post-injury, in comparison to 1.5 
(p<0.0001) and 3 months (p=0.0003) of age and at 4 weeks post-injury in comparison to 1.5 
months (p<0.0001) and 3 months (p<0.0001) of age. Furthermore, TBI significantly increased 
the number of activated microglia at 12 months of age in comparison to 1 (p<0.0001) and 4 
weeks (p<0.0001) sham. Overall, this data indicates that the Iba1 response to injury is 





Figure 3.4. Microglia Iba1 upregulation in the cortex is dependent upon age at injury 
and time post injury. 
 
Representative images of microglial activation in sham and FPI mice, within the neocortical 
region of the injury site (A). The percentage of Iba1 immunoreactivity was significantly 
increased at both 1 week and 4 week FPI in comparison to the corresponding shams in 
animals 3 months of age at injury (B). The percentage of Iba1 immunoreactivity was 
significantly increased in all cohort of animals at 12 months of age compared to 1.5 months 
of age (B). Representative images of resting microglia and activated microglia (C). The 
number of resting microglia in brain injured mice at 1 week post injury was significantly 
decreased in 12-month mice in comparison to 3 months at injury, and at 4 weeks post injury 
was significantly decreased in 12 months compared to 1.5-month-old at injury (D). The 
number of activated microglia was significantly increased at both 1- and 4-weeks post-injury 
in 12-month-old mice, in comparison to the corresponding shams. Additionally, the number 
of activated microglia was significantly increased at 1- and 4-weeks post-injury in 12-month-
old mice compared to mice at 1.5 and 3 months of age (E). Data are presented as mean ± 
SEM. Three-way ANOVA, followed by Turkey’s multiple comparisons tests *p<0.05, 
**p<0.01, ***p<0.001, ****p<0.0001. Scale bar=40um. 
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3.3.5. Axonal degeneration in the internal capsule after mTBI is dependent on the age 
at injury and time post injury  
 
The association between age at injury and axonal vulnerability was investigated within the 
Internal Capsule (IC) (Fig 3.5 A). This is a large axonal tract directly under the pressure wave 
that is elicited in the LFPI model. First the total amount of axon degeneration was quantified 
as a percentage of total area (0% degeneration would be all axons intact) (experimental details 
can be found in Chapter 2) (Fig 3.5 B). An ordinary three-way ANOVA revealed a significant 
interaction between week post injury and age at injury (F2,50 =4.430, p=0.0173). Tukey’s 
multiple comparisons tests identified multiple significant differences. The degree of axonal 
degeneration was significantly increased at both 1 week and 4 weeks post injury in comparison 
to shams in animals injured at 3 months of age (p=0.0012, p<0.0001 respectively) and at 12 
months of age (p=0.0004, p<0.0001 respectively). .There was significantly more axonal 
degeneration at 1 week post injury compared to shams in animals injured at 1.5 months of 
age (p<0.0001). Furthermore, at 4 weeks post injury, in animals injured at 3 months 
(p<0.0001) or 12 months of age (p<0.0001) in comparison to those that were 1.5 months at 
the time of injury, indicating that axonal degeneration increased with increasing age.  
 
Next, the relative number of axonal fragments was quantified (Fig 3.5 C). An ordinary three-
way ANOVA revealed a significant interaction between week post injury and age at injury (F2,49 
=5.550, p=0.0067). Tukey’s multiple comparisons tests identified multiple significant 
differences. The number of axon fragments was significantly higher at both 1 week and 4 
weeks post injury in comparison to shams in animals injured at 3 months of age (p=0.0058, 
p=0.0005 respectively) and 12 months of age (p=0.0458, p=0.0028 respectively). Additionally, 
the number of axonal fragments was significantly increased at 1 week post injury compared 
to shams in animals injured at 1.5 months of age (p<0.0001).  
 
Finally, the size of the axonal fragments was investigated (Fig 3.5 D). An ordinary three-way 
ANOVA revealed a significant interaction between week post injury and age at injury (F2,50 
=6.325, p=0.0036). Tukey’s multiple comparisons tests identified multiple significant 
differences. The size of axonal fragments was significantly increased at 1 week post injury in 
comparison to shams in animals injured at 3 months of age (p=0.0188). Overall, this data 
indicates that the axonal response to injury changes over time in a differential manner 
depending upon age. Specifically, in mice aged 1.5 months at the time of injury axonal 
degeneration improves over time, however in mice aged 3 months and 12 months at injury, 
axonal degeneration does not resolve and instead worsens over time. 
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Figure 3.5. Axonal degeneration in the internal capsule is dependent upon injury, time 
and age following mTBI. 
 
Representative image of mTBI on axons in the internal capsule of the Thy1-YFPH trangenic 
mouse brain (A). The total amount of axon degeneration was significantly higher at 3 months 
and 12 months in comparison to 1.5 months (B). Moreover,  the number of axonal fragments 
was significantly increased at both 1 week and 4 weeks in comparison to shams in mice 
injured at 3 months and 12 months (C). Finally, the size of the axonal fragments was higher 
at 3 months (D). Data are presented as mean ± SEM. Three-way ANOVA, followed by 
Turkey’s multiple comparisons tests *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. Scale 
bar=40um.3.3.6. Spine density did not change after injury independent of age at injury or 
time post-injury. 
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3.3.6. Spine density did not change after injury independent of age at injury or time 
post-injury 
 
In the present study, there was no significant difference between total spines density in injured 
animals compared to shams in the 1.5, 3 or 12 month old cohorts, at either 1 week or 4 weeks 
post injury (Fig 3.6 B; F1,61 =1.579, p=0.2136). Similarly for each individual morphological 
dendritic spine subtype, there were no significant interactions between spine density, age at 
injury or time post for injury for thin (Fig 3.6 C; F1,61 =0.5184, p=0.4743), stubby (Fig 3.6 D; 
F1,61 =0.8654, p=0.3559), or mushroom spines (Fig 3.6 E; F2,61 =1.960, p=0.1666). Overall, the 
mild injury did not change total spines density or the density of individual spine sub-classes 






Figure 3.6. Spines density did not change after mTBI. 
Representative images of mTBI on spine density in the injury site of the Thy1-YFPH mouse 
brain (A). No significant change was found between total spine density (B), as well as the 
density of thin (C), stubby (D) and mushroom (E) spines in injured animals compared to 
shams in the 1.5 months, 3 months or 12 months old cohorts, at either 1 week or 4 weeks 
post injury. Data are presented as mean ± SEM. Three-way ANOVA, followed by Turkey’s 





According to the Centers for Disease Control and Prevention (CDC), children aged 0-4 years, 
adolescents aged 15-19 years, together with older aged over 75 years have a high incidence 
rate of TBI (Laskowitz and Grant, 2016). Increased mortality is reported in the aged relative to 
adolescents and adults following moderate and severe TBI in both animal and clinical studies 
(Hamm et al., 1991, Timaru-Kast et al., 2012, Cheng et al., 2014b). Additionally, it has been 
postulated that brain atrophy in the aged brain may result in augmented diffuse axonal injuries 
and reduced neurorepair capacity (Peters, 2006, Thompson et al., 2006, Antona-Makoshi et 
al., 2015). With regard to the young population, they are generally recognized higher as having 
capacity for neuro-plasticity (Mundkur, 2005, Staudt, 2010, Kolb and Gibb, 2011, Kolb et al., 
2013), however, it has also been reported that young individuals exhibit worse functional 
outcomes following moderate to severe TBI compared with older children and adults (Prins et 
al., 1996, Anderson et al., 2005, Emami et al., 2017), and persist with post-concussive 
symptoms from weeks to years after mTBI (Gagnon et al., 2009, Barlow et al., 2010, Taylor 
et al., 2010, Anderson et al., 2017). With regard to mTBI, brain injuries in the aged are less 
well studied, and it is still under debate whether younger age at the time of injury is associated 
with a better or worse outcome following mild injury. Thus, we investigated specific aspects of 
neuronal and axonal integrity as well as glial activation at discrete time-points throughout the 
lifespan to characterize the injured-brain during acute and chronic phases after injury. In the 
current study, we demonstrated aged (12 months) non-injured brains were characterized by 
a thinner cortex, increased glial activation, as well as higher axonal degeneration relative to 
young and adult brains. Following mTBI, we found age dependent microglial activation over 
time with aged injured animals having higher microglial activation. Furthermore, we also 
observed age at injury and time post injury dependent axonal degeneration, with adult (3 
months) and aged (12 months) animals having higher axonal degeneration after injury 
compared to shams, with these axonal changes evolving over time. 
 
To investigate brain changes that occur over the ageing process, we focused on cellular 
changes, specifically glial activation and axonal degeneration. In accordance with previous 
clinical and experimental findings (Sandhir et al., 2004, Popa-Wagner et al., 2011, Salvadores 
et al., 2017), we observed that the aged (12 months) brains had a thinner neocortex and 
increased pyramidal neuron density in the cortex than both young (1.5 months) and adult (3 
months) brains, as well as higher astrocytic and microglial activation. The increased pyramidal 
neurons density and soma size may due to decreased cortical thickness, as it has been 
suggested there is no overt neuron loss in the ageing process (Egawa et al., 2016). Preceding 
animal studies have observed morphological changes with larger axons and less axons in the 
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optic nerve of aged mice (Adalbert and Coleman, 2013, Stahon et al., 2016). In our study, we 
found that the axonal degeneration in the internal capsule was higher in the aged brain 
compared to younger brains, which may underlie the functional deficits observed in the aged. 
In contrast to previous findings using Golgi staining and fast blue in the prefrontal cortex (Cupp 
and Uemura, 1980, Kabaso et al., 2009), we did not find any age-related spine density 
changes, which may be due to the different method for analysis used. 
 
The lateral fluid percussion injury model has been widely used to mimic clinical mTBI 
pathology (Spain et al., 2010, Alder et al., 2011, Shultz et al., 2011). mTBI did not result in 
gross cortical loss or cavitation in clinical and pre-clinical studies (Iverson et al., 2010, Gao 
and Chen, 2011, Meconi et al., 2018). Moreover, mild injury is associated with low mortality 
rate (0-5%), a loss of consciousness (~2min), and a delay of righting reflex (2-4min) 
(Morehead et al., 1994, Alder et al., 2011, Teng and Molina, 2014, Katz et al., 2015). In the 
current study, results of mortality, loss of consciousness and delay righting reflex suggest that 
the injury used was mild in severity, this was also supported by no significant changes in either 
the neocortex thickness or neuronal population density of cell size across the lifespan. 
Furthermore, Hamm and colleagues have reported longer righting response time in aged (20 
months old) relative to young (3 months old) brain injured mice (Hamm et al., 1991), however, 
we observed the period of unconsciousness and righting reflex time in aged brain injured mice 
did not differ from younger brain injured mice. This discrepancy may due to the differences in 
injury severity, as injury used in Hamm’s study, as the injury pulse was between 1.7 to 1.8 atm 
and 20% mortality and 50% mortality was reported in the study. 
 
Kou and VandeVord reported that glia are acutely activated after TBI and have been proposed 
to have both beneficial and detrimental effects (Kou and VandeVord, 2014). Unlike previous 
studies (Goodrich et al., 2016, Rodriguez-Grande et al., 2018), we did not observe that the 
mild injury significantly change activated astrocytes in the injured cortex in either adult or aged 
brains at either 1week or 4 weeks post-injury, this may due to insufficient numbers of adult 
and aged injured brains. Furthermore, in contrast to previous findings (Tzekov et al., 2016, 
Ferguson et al., 2017b, Mouzon et al., 2018b), we did not observe the highest astrocytic 
activation after injury in the aged cohort, which may be relevant to the injury severity and site 
measured. Logsdon and colleagues reported increased GFAP mRNA and protein expression 
has been observed at earlier stages after injury (2 days and 3 days post injury) (Logsdon et 
al., 2017). In the current study, astrocyte activation was observed after injury in the young 
brain injured mice compared to sham operated mice, at later stages, astrocytic activation was 
resolved at 4 weeks post-injury in young brain-injured mice. Microglial activation after mTBI 
has been observed in the corpus callosum and in the thalamic sites (Lafrenaye et al., 2015, 
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Goodrich et al., 2016). Consistent with previous animal studies (Lafrenaye et al., 2015, 
Goodrich et al., 2016), in the current study, we also observed mild injury significantly activated 
microglia within the injured cortex in adult brains at both 1 week and 4 weeks post-injury. 
However, we did not observe injury related microglial activation in either adult or aged animals. 
The underlying reason may be due to the resolution of injury related microglial activation in 
adult and aged animals was earlier compared to young animals, thus, investigation at earlier 
post injury time points is warranted in future studies. Consistent with previous animal studies 
(Kumar et al., 2013, Ferguson et al., 2017b, Cheng et al., 2018), we observed that microglial 
activation was higher in aged injured brains compared to young injured brains. In order to 
further understand the role of activated microglia, further studies classifying microglial 
phenotypes and analyzing cytokines as well as chemokine are warranted. 
 
Previous studies have observed axonal morphological and functional changes in the brain 
after mTBI, most of them investigated the injured cortex and the corpus callosum (Mierzwa et 
al., 2015, Henninger et al., 2016, Chen et al., 2018, Chuckowree et al., 2018). In the current 
study we found, in the internal capsule, that mTBI induced significantly higher axonal 
degeneration and more axonal fragments in both adult and aged cohrts at both 1 week and 4 
weeks post injury. In contrast, mTBI increased axonal degeneration and axonal fragments at 
1 week post injury and resolved at 4 weeks post injury. This finding suggests that the axonal 
pathology in the internal capsule was time and age dependent, with both short-term and long-
term existing in adult and aged mice but only short-term onset in young mice, which may 
underlie the long-lasting functional deficits observed in old patients and eariler recovery in 
young patients (Pendlebury et al., 1999, Kinnunen et al., 2011, Li et al., 2019). Previous 
studies have observed exacerbated white matter loss in adult but not in adolescent mice at 3 
months after repetitive mTBI (Mannix et al., 2017). In the current study, we found the axonal 
changes in the internal capsule at 4 weeks post injury after mild injury were only observed in 
adult and aged brain-injured mice but not in young mice. This suggests age dependent axonal 
degeneration after mTBI. Moreover, it may also suggest the young brain is resilient in regards 
to axonal degeneration or the axonal degeneration occurs earlier. Previous studies have 
observed aged brains had higher rates of axonal degeneration in the corpus callosum 
compared to young brains at acute and chronic time points after rmTBI (Ferguson et al., 
2017b, Mouzon et al., 2018b). Similarly in the current study, we found the axonal changes in 
the internal capsule were higher in the aged injured brains compared to young injured brains 
at 4 weeks post-injury, which may suggest the vulnerability of aged brains to injury, and 
specifically axonal pathology.  
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Previous studies suggest higher astrocytic and microglial activation may play an important role 
in promoting axonal damage in the injured brains, as higher inflammation may result in a delay 
in the clearance of axonal degeneration debris (Kotter et al., 2005, Zhao et al., 2006). Our 
study however found that the astrocyte and microglia activation after injury was highest at 1 
week post injury and 4 weeks post injury respectively, whereas the axonal degeneration 
occurred at both 1 week and 4 weeks post-injury. This discrepancy in timing suggests that 
glial activation does not necessarily correlate with axonal pathology, a view supported by 
Hilla’s study (Hilla et al., 2017). Pathological changes in the internal capsule have been linked 
to functional deficits and poor recovery as well as quality of life (Pendlebury et al., 1999, Lee 
et al., 2000, Blasi et al., 2015, Hyett et al., 2018). The observed age dependent axonal 
degeneration in our study may underlie these age relevant outcomes following mTBI. The 
vulnerability of the aged brain to axonal pathology may due to the thinner neocortex, which 
may increase proximity between the site of impact and the underlying white matter in turn.  
 
In summary, this data supports previous investigations reporting that the aged brain is 
characterized by a thinner cortex, increased glial activation as well as pronounced axonal 
degeneration in the internal capsule. Furthermore, we found axonal degeneration and 
microglial activation after mTBI was age and time dependent, with axonal degeneration lasting 
at both short-term and long-term in adult and aged but resolved at later timepoint in young 




4. THE THERAPEUTIC POTENTIAL OF THE MICROTUBULE STABILIZING AGENT 




mTBI results in substantial costs at individual and societal levels, with estimated total 
expenditures of 1.2 million spent on mTBI (Gerberding, 2003, Faul et al., 2010, Dewan et al., 
2018). Additionally, there is no effective cure. mTBI does not cause overt morphological 
changes to the brain, however, it can set in motion an insidious cascade of neural alterations 
manifesting in ongoing and long-term impairments in neurological and cognitive function, as 
well as personality and behavioural changes (Eme, 2017, Shin et al., 2017, McInnes et al., 
2017, Eman Abdulle and van der Naalt, 2019, Lai et al., 2019, Richey et al., 2019, Sun et al., 
2019). mTBI induces widespread axonal impairments (including axonal swelling and 
degeneration) in the cortex and particularly in the white matter tracts as well as somato-
dendritic compartment changes such as soma atrophy, dendritic complexity reduction and 
decreased dendritic spine density. Glial activation following mTBI has also been observed 
(Dikranian et al., 2008, Spain et al., 2010, Gao and Chen, 2011, Greer et al., 2011, Liu et al., 
2013, Katz et al., 2015, Henninger et al., 2016, Winston et al., 2016, Chen et al., 2018, 
Rodriguez-Grande et al., 2018, Zhao et al., 2018, Clement et al., 2019, Powell et al., 2019). 
 
Microtubules (MT) serve as the major railways for organelles and other cargoes transported 
within axons and dendrites. Appropriate MT function underlies the growth and maintenance 
of the axon, as well as the development and plasticity of the dendritic arbors (Conde and 
Cáceres, 2009). Microtubules are also an important constituent of non-neuronal cells in the 
brain. In oligodendrocyte, morphologically, microtubules can be classified into radial 
microtubules which are found along branched processes extending toward the axon, and 
lamellar microtubules which are distal microtubules mediating vesicular trafficking into inner 
myelin layers (Snaidero et al., 2014). Astrocyte processes contain primarily microtubules at 
birth, but these are entirely replaced by intermediate filaments during maturation (Peters and 
Vaughn, 1967). Microtubules in astrocyte can undergo extension, retraction and branching 
events (Eom et al., 2011). Microglia are highly dynamic, extending and retracting their 
processes. It has been observed that the major, more stable, processes contain microtubules 
while minor processes contain actin rich filopodia with dynamic processes (Bernier et al., 
2019). MT disruption in neurons has been widely observed following brain and spinal cord 
injuries (Brunden et al., 2012, Tang-Schomer et al., 2012, Baas, 2014, Brizuela et al., 2015). 
Therefore, manipulating microtubules could possibly provide a novel therapy in these injuries 
(Brunden et al., 2012, Baas, 2014, Dent, 2017). Traditionally, microtubule stabilizing agents 
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including taxanes and epothilones have been widely used to inhibit cancer cell growth at high 
dosage (Zhao et al., 2009). Compelling experimental studies from brain injury, spinal cord 
injury, and neurodegenerative disease models have found that when used at low dosage, 
these agents could have a range of additional beneficial outcomes, including promoting axon 
regeneration, decreasing axon degeneration, increasing dendritic spine density, dampening 
glial responses, enhancing adaptive neural alterations and improving cognitive and 
behavioural outcomes (Brunden et al., 2012, Hellal et al., 2011, Sengottuvel et al., 2011, Hur 
and Lee, 2014, Popovich et al., 2014, Brizuela et al., 2015, Cross et al., 2015, Ruschel et al., 
2015, Jang et al., 2016, Penazzi et al., 2016, Yap et al., 2017, Chuckowree et al., 2018, 
Ruschel and Bradke, 2018, Sandner et al., 2018, Xiong et al., 2019). 
 
The mechanisms of epothilones include preventing microtubules depolymerization and 
promoting the tubulin polymerization to microtubules (Altmann et al., 2000, Chen et al., 2008). 
In regard to the CNS, epothilones are able to cross the blood brain barrier, have higher 
solubility, and have been shown to remain in the CNS for several days without any observable 
side effects (Andrieux et al., 2006, Brunden et al., 2011). Preclinical studies have 
demonstrated that the MT stabilizing agent epothilone D may be beneficial to treat brain injury, 
spinal cord injury, and neurodegenerative diseases (Brunden et al., 2010, Barten et al., 2012, 
Zhang et al., 2012, Cartelli et al., 2013, Fan et al., 2014, Brizuela et al., 2015, Ballatore et al., 
2016, Penazzi et al., 2016, Yap et al., 2017, Chuckowree et al., 2018, Ruschel and Bradke, 
2018, Sandner et al., 2018, Xiong et al., 2019). Our recent in vivo and in vitro studies have 
demonstrated epothilone D treatment significantly improved MT stability, reduced axonal 
fragmentation, and increased mushroom spine density following mild injury (Brizuela et al., 
2015, Yap et al., 2017, Chuckowree et al., 2018). Another in vitro study showed that epothilone 
B could be both beneficial and detrimental to axonal growth depending on the age and type 
of a neuron (Jang et al., 2016). Thus, in order to further investigate the therapeutical potential 
of epothilone D and to determine if the drug effect is age dependent, we explored the short-
term and long-term effects of peripherally administered epothilone D following a single mild 
LFPI in both young and adult mice. 
 
4.2. MATERIALS AND METHODS 
 
Studies were performed on young (1.5 months) and adult (3 months) Thy1-YFPH transgenic 
male mice. Mice were randomized to the injury group (n=48 young, and n=48 adult) and the 
sham group (n=48 young, and n=48 adult). Lateral fluid percussion injury (LFPI) of mild 
severity (1.29±0.11 atmospheres) was delivered to the ‘inhjury’ cohort. At 24 hours following 
the injury/sham-operation, animals were administered with either epothilone D (EpoD) 
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(2mg/kg, i.p; Abcam, ab143616, Cambridge, UK; n=24 injury and n=24 sham-operated) or 
dimethyl sulfoxide (DMSO) (vehicle control; i.p; Sigma, RNBD0643, Missouri, USA; n=24 
injury and n=24 sham-operated), and then with weekly injection of same dosage of epothilone 
D or equivalent volume of DMSO (Fig 4.1). The specific dose of EpoD was chosen as there 
was in the absence of major side effect (Scott et al., 2008), and the potential effectiveness of 
this dosage has been observed among mTBI and ALS animal models (Chuckowree et al., 
2018, Clark et al., 2018). However, using various doses could be informative in future studies. 
Additionally, the rationale for choosing the 24 hrs delay in drug injection is allow for parameters 
of clinical relevance. For example, it takes a while for injured patients with transportation, 
clinical assessment and diagnosis before the drug treatment. Half of mice were perfused at 1 
week post injury (n=6 young FPI EpoD 1wk, n=6 young FPI DMSO 1wk, n=6 young sham 
EpoD 1wk, n=6 young sham DMSO 1wk, n=6 adult FPI EpoD 1wk, n=6 adult FPI DMSO 1wk, 
n=6 adult sham EpoD 1wk, n=6 adult sham DMSO 1wk) and the other half were perfused at 
4 weeks post injury (n=6 young FPI EpoD 4wk, n=6 young FPI DMSO 4wk, n=6 young sham 
EpoD 4wk, n=6 young sham DMSO 4wk, n=6 adult FPI EpoD 4wk, n=6 adult FPI DMSO 4wk, 
n=6 adult sham EpoD 4wk, n=6 adult sham DMSO 4wk). For the 4 weeks cohort, mice 
received the first dose at 24 hr after injury then once a week till 4 weeks post injury. Details 
regarding immunohistochemistry protocols can be found in Chapter 2. Statistically significant 














Figure 4.1 Experimental flow charts. 
 
A lateral fluid percussion injury/sham procedure was conducted in both young (1.5 months 
old) and adult (3 months old) Thy1-YPFH mice. At 24 hours post injury, all the mice were 
injected with either EpoD or DMSO, and then with weekly injections of same dosage of 
EpoD or equivalent volume of DMSO. Animals were perfused at either 1 week post injury or 










4.3.1. EpoD did not affect cortical architecture in young and adult mice 
 
The injury pulse used in young (1.5 months) injured mice was comparable to that given to 
adult (3 months) injured mice (Fig 4.2 A; p=0.4456). LFPI was followed by a short interval of 
apnoea (Fig 4.2 B) in animals at 1.5 months and 3 months of age at injury, additionally, the 
duration of apnoea was significantly longer in young (1.5 months) brain-injured mice in 
comparison to adult (3 months) brain-injured mice (p=0.0036). In regard to the delayed righting 
reflex time, a Two-way ANOVA revealed no significant interaction between injury and age at 
injury (Fig 4.2 C; F1,91 =8.113, p=0.0054). The righting reflex time however was significantly 
increased following LFPI compared to shams in animals injured at the age of 1.5 months 
(p<0.0001) and 3 months (p<0.0001). As to the cortical thickness, an ordinary Three-way 
ANOVA revealed no significant interaction between week post injury and age at the time of 
injury in sham-operated mice (Fig 4.2 E; F1,39 =0.01270, p=0.9108) and brain injured mice (F 
4.2 F; F1,39 =1.231, p=0.2741). Similarly for the YFP positive cell density and the cell soma 
size, there was no significant interaction between week post injury and age at the time of injury 
in sham-operated mice (Fig 4.2 G; F1,39 =0.001166, p=0.9729; Fig 4.2 I; F1,39 =0.6855, 
p=0.4127, respectively) and brain-injured mice (Fig 4.2 H; F1,39 =0.2087, p=0.6503; Fig 4.2 J; 





Figure 4.2. EpoD did not influence neuronal health in young and adult mice. 
 
The injury pulse was not different between young (1.5 months) and adult (3 months) brain-
injured cohorts (A). LFPI caused a short period of apnoea in animals of 1.5 months and 3 
months old, and the apnoea was longer in brain-injured animals at the age of 1.5 months 
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compared to 3 months (B). LFPI induced a significant increase in righting reflex time in both 
1.5 months and 3 months old mice, and there was no significant difference between injured 
mice at 1.5 months old and at 3 months old (C). Representative image of LFPI in an young 
Thy1-YFPH mouse brain with EpoD treatment (D). Cortical thickness did not differ between 
EpoD treatment and DMSO treatment in sham-operated mice (E) and brain-injured mice (F) 
at the age of 1.5 months and 3 months at injury, at either 1 week or 4 weeks post injury. The 
YFP positive cell density in the neocortex was not different between EpoD treatment and 
DMSO treatment in sham-operated mice (G) and brain-injured mice (H) at the age of 1.5 
months and 3 months at injury, at either 1 week or 4 weeks post injury. The YFP positive cell 
soma size in the neocortex was not different between EpoD treatment and DMSO treatment 
in sham-operated (I) and brain-injured mice (J) at the age of 1.5 months and 3 months at 
injury at either 1 week or 4 weeks post injury. Data are presented as mean ± SEM. Three-
way ANOVA, followed by Turkey’s tests **p<0.01, ****p<0.0001. Scale bar=200um. 
 
4.3.2. EpoD treatment did not alter the response of gliosis in young and adult mice  
 
The effect of EpoD on GFAP immunoreactivity was investigated within the neocortical region 
of the injury site (experimental details can be found in Chapter 2) in sham-operated mice (Fig 
4.3 C) and brain-injured mice (Fig 4.3 D). An ordinary Three-way ANOVA revealed no 
significant interaction between week post injury and age at injury in sham-operated mice (F1,39 
=2.513, p=0.1210) and brain-injured mice (F1,39 =0.2652, p=0.6095). However, astrocyte 
activation in brain-injured EpoD treated mice was significantly resolved at 4 weeks post injury 
in comparison to 1 week post injury with either DMSO or EpoD treatment in mice at the age 
of 1.5 months (p=0.0115, p=0.0083, respectively) and at the age of 3 months (p=0.0011, 
p=0.0007, respectively). The effect of EpoD on Iba1 immunoreactivity was investigated within 
the same region of analysis as GFAP (experimental details can be found in Chapter 2) in 
sham-operated mice (Fig 4.3 E) and brain injured mice (Fig 4.3 F). An ordinary Three-way 
ANOVA revealed no significant interaction between week post injury and age at injury in sham-
operated mice and brain-injured mice (F1,40 =0.2913, p=0.5924; F1,39 =0.4788, p=0.4930, 
respectively). However, microglial activation was significantly resolved at 4 weeks post injury 





Figure 4.3. EpoD did not influence astrocytic or microglial activation in both young 
and adult mice. 
 
Representative image of mTBI on astrocyte (A) and microglia (B) in the neocortex. In the 
injured neocortex, the percentage of GFAP immunoreactivity was not significantly influenced 
by EpoD treatment compared to DMSO treatment in either sham-operated mice (C) or brain-
injured mice (D) at the age of 1.5 months and 3 months at injury. Similarly, the percentage of 
Iba1 immunoreactivity was not significantly affected by EpoD treatment in comparison to 
DMSO treatment in either sham-operated mice (E) or brain-injured mice (F) at the age of 1.5 
months and 3 months at injury. Data are presented as mean ± SEM. Three-way ANOVA, 
followed by Turkey’s multiple comparisons tests. Scale bar=50um. 
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4.3.3. EpoD exacerbated axonal degeneration after mTBI in the internal capsule in adult 
mice but was ineffective in young mice 
 
The effect of EpoD on axonal degeneration in the IC over time was investigated in 1.5 and 3 
months old mice injured and sham mice (Fig 4.4 A). In regard to the total amount of axonal 
degeneration, an ordinary Three-way ANOVA revealed no significant interaction between 
week post injury and age at injury (Fig 4.4 B; F1,31 =2.131, p=0.1544). However there was a 
significant interaction between age at injury and treatment (F1,31 =32.01, p<0.0001). Tukey’s 
multiple comparisons tests identified multiple significant differences. Axonal degeneration was 
significantly increased at 4 weeks post injury with EpoD treatment in comparison to DMSO 
treatment in animals injured at 3 months old (p=0.0026). Furthermore, the axonal 
degeneration at 4 weeks post injury with EpoD treatment in 3 months old mice was significantly 
pronounced in comparison to axonal degeneration at 4 weeks post injury with EpoD treatment 
in 1.5 months old (p<0.0001), indicating that the effect of EpoD on axonal degeneration 
worsened over time.  
 
As to the relative number of axonal fragments (Fig 4.4 C). An ordinary Three-way ANOVA 
revealed no interaction between week post injury and age at injury (F1,30 =1.6460, p=0.2093). 
However there was a significant interaction between age at injury and treatment (F1,30 =14.98, 
p=0.0005). Tukey’s multiple comparisons tests identified multiple significant differences. 
There was a significant increase in the number of axonal fragments at 4 weeks post injury with 
EpoD treatment in animals injured at 3 months of age compared to 1.5 months of age 
(p=0.00071). 
 
In regard to the size of the axonal fragments following EpoD treatment (Fig 4.4 D). An ordinary 
Three-way ANOVA revealed no interaction between week post injury and age at injury (F1,32 
=0.0384, p=0.8458). However there was a significant interaction between age at injury and 
treatment (F1,32 =5.061, p=0.0315). Tukey’s multiple comparisons tests identified no significant 
differences.  
 
Together these data suggests EpoD was ineffective on axonal degeneration in young brain 
injured mice, but it significantly increased axonal degeneration in adult brain injured mice at 4 




Figure 4.4. EpoD exacerbated axonal degeneration after mTBI in the internal capsule 
in adult mice and was ineffective in young mice. 
 
Representative images of mTBI on axons in the internal capsule of the Thy1-YFPH 
transgenic mouse brain (A). The total amount of axon degeneration was significantly 
increased by EpoD treatment compared to DMSO treatment at 4 weeks post injury in brain-
injured animals at 3 months old, the axonal degeneration at 4 weeks post injury in brain 
injured animals at 3 months old at injury was significantly higher in comparison to 4 weeks 
post injury in brain injured animals at 1.5 months old at injury (B). The number of axon 
fragments at 4 weeks post injury in EpoD treated mice was significantly higher in animals at 
3 months old at injury in comparison to 1.5 months at  injury (C). The size of axon fragments 
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did not change after EpoD treatment compared to DMSO treatment in brain injured animals 
at either 1.5 months or 3 months old at injury (D). Data are presented as mean ± SEM. 
Three-way ANOVA, followed by Turkey’s multiple comparisons tests  **p<0.01, ***p<0.001, 
****p<0.0001. Scale bar=40um. 
 
4.3.4. EpoD did not affect the total spine density or density of sub-classes of spines in 
young and adult mice 
 
In the current study, there was no significant difference in total spine density in EpoD treated 
animals in comparison to DMSO treated sham-operated animals (Fig 4.5 A; F1,40 =0.01585, 
p=0.9004) and brain-injured animals (Fig 4.5 B; F1,39 =0.0110, p=0.9172) at either 1.5 months 
or 3 months old cohorts, at either 1 week or 4 weeks post injury. Similarly for each individual 
morphological subtype, there were no significant interactions between spine density, age at 
injury of time post injury for thin spines in sham-operated mice (Fig 4.5 C; F1,39 =3.062, 
p=0.0880) and brain-injured mice (Fig 4.5 D; F1,39 =0.8377, p=0.3657), stubby spines in sham-
operated mice (Fig 4.5 E; F1,39 =0.1668, p=0.6852) and brain-injured mice (Fig 4.5 F; F1,39 
=0.0218, p=0.8833), or mushroom spines in sham-operated mice (Fig 4.5 G; F1,39 =0.03692, 
p=0.8486) and brain-injured mice (Fig 4.5 H; F1,39 =1.131, p=0.2940). Overall, EpoD did not 










Figure 4.5. EpoD did not affect the density of total spines or the density of sub-
classes of spines in young and adult mice. 
 
Total spines density was not influenced by EpoD treatment compared to DMSO treatment in 
either sham-operated mice (A) or brain-injured mice (B) at the age of 1.5 months and 3 
months at injury. Likewise, as to each individual subtype, the density of thin spines (C and 
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D), stubby spines (E and F), or mushroom spines (G and H) was not affected by EpoD 
treatment in comparison to DMSO treatment in sham-operated mice or brain-injured mice at 
the age of 1.5 months and 3 months at injury. Data are presented as mean ± SEM. Three-





Despite limited overt morphological changes to the brain in mTBI patients, compelling 
evidence suggests neural circuitry impairments play an important role in the alterations of 
neurological function, including physical, psychosocial, neurosensory and cognitive function 
(McMahon et al., 2014, Wang and Li, 2016, Wilde et al., 2016, De Koning et al., 2017). The 
cellular changes contributing to mTBI deficits are less well studied, and currently there are no 
effective treatment to rescue these changes. Previous in vitro studies in our lab using cultured 
primary neurons have shown the potential of axonal sprout promotion and reduction of injury 
related axonal fragments by epothilone D treatment (Brizuela et al., 2015, Yap et al., 2017). 
Additionally, another in vivo study in our lab has further suggested the therapeutic potential of 
epothilone D in mTBI by reporting an increase in the density of mushroom spines after a single 
dose of epothilone D immediately following mTBI in adult mice (Chuckowree et al., 2018). In 
the present study, we further investigated therapeutic potential of the drug by applying multiple 
low doses of epothilone D at 24 hours after mTBI in both young (1.5 months) and adult (3 
months) mice. Consistent with previous studies, we observed mTBI induced apnoea and 
increased loss of consciousness in both young (1.5 months) and adult (3 months) mice. 
Additionally, we further supported findings that intraperitoneally injected epothilone D was able 
to cross the blood brain barrier, and both single and multiple doses of epothilone D in our 
study did not trigger gross neural population and glial activation changes. Importantly, we 
found that although there wasn’t any effect on axonal degeneration following epothilone D 
treatment in young cohorts, epothilone D significantly exacerbated axonal degeneration in 
adult brain-injured mice, potentially suggesting the need for age dependent drug therapy for 
mTBI patients.  
 
Similar to previous studies (Smith and Meaney, 2000, Spain et al., 2010, Wang and Ma, 2010, 
Ekmark-Lewén et al., 2013, Smith et al., 2013a, Hill et al., 2016) and results in Chapter 3, in 
the present study, we found that the mild injury did not alter architecture in the cortex, 
supported by in the absence of overt neuron loss, neuronal atrophy and cortical loss at both 
1 week and 4 weeks after injury. Additionally, LFPI caused a short duration of apnoea and 
righting reflex both in young (1.5 months) and adult (3 months) animals. Similar to findings in 
Chapter 3, the righting reflex time was not different between young and adult mice, however, 
the duration of apnoea was significantly longer in young mice compared to adult mice. This is 
similar to Rowe and colleagues findings, in which mild midline FPI induced duration of apnoea 
was significantly longer in juvenile (17 days old) and adolescent (35 days old) rats (Rowe et 
al., 2018). Thus, even without difference in righting reflex time between young and adult mice 
following mTBI, the duration of apnoea was longer in young mice compared to adult mice.  
 60 
In the present study, we further confirmed that both single and multiple doses of epothilone D 
did not cause overt morphological changes to cortical pyramidal neurons in both young (1.5 
months) and adult (3 months) mice, supported by no significant changes in the cortical 
thickness, the YFP positive cell density and the cell soma size (Chuckowree et al., 2018). 
Furthermore, similarly to previous studies (Hellal et al., 2011, Ruschel et al., 2015, 
Chuckowree et al., 2018), we showed that injury induced astrocytic activation was not affected 
by epothilone D treatment in both adult mice and young mice. Some previous studies 
(Popovich et al., 2014, Ruschel et al., 2015) have suggested microtubule stabilizing agent 
drugs can affect astrocyte activation, however, Popovich and colleagues used taxol, and 
Ruschel and colleagues applied epothilone B in a model of spinal cord injury. Therefore, the 
discrepancy may be due to variance in drugs and types of injury. The influence of epothilone 
D on microglial activation is less well studied. Our findings suggest that microglial activation 
is not affected by both single and multiple doses of epothilone D in both young and adult mice 
after mTBI. A previous study from our laboratory (Clark et al., 2018) has reported that 
epothilone D injection (2 mg/kg at 5 days intervals) significantly increased microglial activation 
in the end stage of an amyotrophic lateral sclerosis (ALS) mouse model, suggesting 
epothilone D may have an effect on microglial activation at longer timepoints and in different 
disease contexts. Thus, further studies investigating chronic effects of epothilone D after mTBI 
are warranted. 
 
Microtubule stabilizing agent drugs have been reported with promising results in spinal cord 
injuries, where they have been reported to promote axonal regeneration and improve walking 
function after spinal cord injury. The underlying mechanisms may be relevant to reducing 
fibrotic scarring and promoting regrowth of injured spinal cord axons following microtubule 
stabilizing agent drugs delivery (Hellal et al., 2011, Ruschel et al., 2015, Ruschel and Bradke, 
2018). epothilone D has been reported to stabilize microtubules, promote of neurite outgrowth, 
and reduce injury-related axonal fragments in cultured neurons (Brizuela et al., 2015, Yap et 
al., 2017). In mouse models of neurodegenerative diseases, low doses of epothilone D 
significantly increased MT density and axonal integrity (Brunden et al., 2010). Additionally, 
epothilone D treatment was also found to reduce axonal dystrophy and increase axonal MT 
density in a Tau transgenic mouse model (Zhang et al., 2012). Furthermore, it has been 
reported that epothilone D was able to prevent Aβ-induced axon and cell loss in Tau 
transgenic mouse model (Nishioka et al., 2019). In a cerebral ischemic model, epothilone D 
has been found to alleviate microtubule disruption and CA1 neuronal death (Xiong et al., 
2019). In the present study, we found epothilone D did not affect injury induced axonal 
degeneration at 1 week post-injury in adult brain-injured mice, which is similar to our previous 
study (Chuckowree et al., 2018). Furthermore, we also validated the ineffectiveness of 
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epothilone D in improving measures of axonal degeneration at both 1 week and 4 weeks post-
injury in young brain-injured mice. However, we found multipe doses of epothilone D (4 
injections at 1 week interval) significantly exacerbated axonal degeneration in the internal 
capsule compared to DMSO treatment in adult brain-injured mice. These findings suggest the 
effect of epothilone D on axonal degeneration following mTBI was age dependent. The age 
dependent effect of the drug has been reported with an epothilone D analog, epothilone B. It 
has been observed that epothilone B promoted axonal growth of young dorsal root ganglion 
(DRG) and cortical neurons, while the same concentration drastically prevented axon growth 
of adult sensory neurons and caused severe toxicity in adult DRG neurons (Jang et al., 2016). 
It is possible that the proportion of stable microtubules is different depending on neuron age, 
as most stable microtubules in neurons play an important role in maintaining the structural 
integrity, while dynamic microtubules provides the basis for neural plasticity and structural 
modifications in response to stimuli. Additionally, it is plausible that a neuron of a particular 
age harbors MT of unique biochemical and biophysical properties that control MT stability 
(Jang et al., 2016). 
 
It has been reported that a subnanomolar concentrations of epothilone D could completely 
reverse Aβ-induced spine loss and also increase thin spin density in an in vitro study (Penazzi 
et al., 2016). Additionally, it has been also reported that a single low dose of epothilone D 
administered immediately after mild injury significantly increased the density of mushroom 
spines in a LFPI mouse model (Chuckowree et al., 2018). However, in the current study, we 
did not observe any changes in the overall density or sub-class density of spines following the 
drug treatment in either young or adult mice. The discrepancy may due to different timepoints 
of drug injection - Chuckowree and colleagues injected the drug immediately after injury, while 
in the current study we delivered the drug at 24 hours after injury, this may suggest the effect 
of epothilone D on spine density is dependent on the delivery timepoints. 
 
In summary, this data supports previous investigations reporting that epothilone D did not 
affect neuronal density and glial activation in the neocortex in either young or adult mice. 
Furthermore, we showed that age dependent effects of epothilone D on injury related axonal 
degeneration in the internal capsule with ineffectiveness in young animals and increased 
axonal degeneration in adult animals. Our findings may support the need for consideration of 
age when designing drug therapy for mTBI. 
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5. THE INFLUENCE OF SEX AND AN ADDITIONAL INJURY ON THE CELLULAR 




mTBI has been recognized as a silent epidemic, however, it is also characterized by a 
disturbance in brain function with neurological symptoms (Carroll et al., 2004, Hossain et al., 
2019). The majority of TBI studies are performed in male populations and/or using male animal 
models, partially due to the overall higher TBI incidence in males than females (Hillbom and 
Holm, 1986, Hirtz et al., 2007, Taylor et al., 2017), with females sustaining approximately only 
a third of TBIs resulting in hospitalisation (Faul et al., 2010, Saverino et al., 2016). It is, 
however, also reported that females typically have a high prevalence of mild TBI due to 
domestic violence, and as a result of high participation in health care occupations (Chang et 
al., 2014, Covassin et al., 2016, Colantonio, 2016, Lutgendorf, 2019), while males are more 
likely to suffer a moderate to severe brain injury resulting from high-risk activities, such as 
professional contact sports, the construction industry, or military occupations (Diamond et al., 
2007, Cohen, 2013, Chang et al., 2014, Raukar et al., 2014, Chang et al., 2015). In sport-
related injuries as well as former military personnel, repetitive mTBI has been widely observed. 
While behavioural and cognitive deficits resulting from a single mTBI may resolve over time 
after injury, clinical studies have shown additional injuries may increase the susceptibility to 
long lasting functional impairments (Cheng et al., 2014a, Ferguson et al., 2017a, Gunter et 
al., 2018, McAllister and Wall, 2018, Merritt et al., 2018, Misquitta et al., 2018, Kontos et al., 
2019, Ruiter et al., 2019). Furthermore, repetitive injuries may be associated with increased 
risk of the developing later-life neurodegenerative diseases (Lehman et al., 2012) including 
Alzheimer’s disease (AD) and chronic traumatic encephalopathy (CTE) (Guo et al., 2000, 
Plassman et al., 2000, Fleminger et al., 2003, Guskiewicz et al., 2005, McCrory et al., 2013, 
McKee et al., 2013, Smith et al., 2013b, Baugh et al., 2014, Nordström et al., 2014, Abrahams 
et al., 2019).  
 
Sex dependent outcomes following TBI have been reported in a number of studies, but with 
mixed findings. In some clinical studies females showed worse outcomes across multiple 
measures, including duration of post-traumatic amnesia, memory impairment, insomnia, and 
mortality (Farace and Alves, 2000, Biswas et al., 2017), as well as self-reported headaches, 
dizziness, and depression (Colantonio et al., 2010, Merritt et al., 2019, Yue et al., 2019). 
However, other studies report no significant difference in working memory performance 
between female and male patients after mTBI (Hsu et al., 2015). In pre-clinical studies, some 
studies have reported better performance in female animals compared to male animals after 
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TBI (Dick, 2009, Bazarian et al., 2010, Frommer et al., 2011, Laker, 2011, Covassin and Bay, 
2012, Velosky et al., 2017, Clevenger et al., 2018). However, in other investigations no sex 
dependent differences in behavioural or pathological outcome in young mice after repetitive 
mild injures were observed, whilst others report that female mice showed worse motor 
outcome after repetitive mild injuries compared to male mice (Ferguson et al., 2017b).  
 
Furthermore, sex related differences in inflammation responses after injury have also been 
reported. Späni and colleagues, report a significant increase in IL-6, TNFα, and C-C Motif 
Chemokine Ligand 2 (CCL2) in adult female mice compared to male mice after TBI, whereas 
the anti-inflammatory cytokine IL-10 was elevated in males but not in females (Späni et al., 
2018). Sex related differences have also been reported for other pro-inflammatory factors. 
Both cyclooxygenase 2 (COX-2) and inducible nitric oxide synthase (iNOS) are increased at 
24hr after TBI, but COX-2 is significantly elevated in males whereas iNOS is significantly 
increased in females compared to males (Gunther et al., 2015). Additionally, male pigs show 
a higher IL-6 increase at 4hr after TBI compared to female pigs receiving the same injury 
(Armstead et al., 2016). 
 
To understand the pathological and behavioural changes following repetitive mTBI, 
experimental studies have tried to replicate the changes observed in repetitive mTBI patients. 
As with sex investigations, results from experimental studies are mixed, in which variance in 
numbers of injuries and interval between injuries may play a role. While some suggest shorter 
intervals between injuries are associated with exacerbated pathology, others found the interval 
between injuries did not affect long term pathological and behavioural outcomes (Cheng et 
al., 2014a, Selwyn et al., 2016, Multani et al., 2016, Ferguson et al., 2017a, Merritt et al., 
2018). Thus, additional experimental studies are needed to better characterize the influence 
of the number of injuries sustained and the time interval between injuries on the pathological 
outcomes following repetitive mTBI.  
 
Mixed clinical and experimental sex related findings after TBI highlight the importance of 
further investigating the influence of sex on outcomes following TBI. Those observed sex 
dependent behavioural and pathological changes after TBI may be partially attributed to the 
cellular and subcellular changes between sexes, in which, neuronal and glial reactions may 
play an important role (Conejo et al., 2005, Pesaresi et al., 2015, Villa et al., 2018). 
Furthermore, in order to identify potential therapeutic strategies to alleviate or prevent damage 
and deficits after repeated mTBI, the pathophysiological changes after repeated mTBI need 
further investigation. Thus, the final experimental chapter of this thesis presents two studies 
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investigating how the potential risk factors, sex and additional injury, influence the cellular and 
subcellular reactions after lateral fluid percussion in a mouse model. 
 
5.2. MATERIALS AND METHODS  
 
The influence of sex study was performed on adult (3 months) Thy1-YFPH transgenic male 
(same mice used in Chapter 3) and female mice. Female mice were randomized to the injury 
group (n=12) and sham group (n=12). Lateral fluid percussion injury (LFPI) of mild severity 
(1.34±0.12 atmospheres) was delivered to the injured mice. Half of the mice were perfused at 
1 week post injury (n=6 female FPI 1wk and n=6 female sham 1wk) and the other half were 
perfused at 4 weeks post injury (n=6 female FPI 4wk and n=6 female sham 4wk). 
 
The influence of an additional injury study was performed on adult (3 months) Thy1-YFPH 
transgenic male mice. The single brain injured mice were the same mice in Chapter 3. With 
regards to mice with repetitive mTBI, firstly, identical surgical procedures and lateral fluid 
percussion brain injury were performed (details can be found in Chapter 2), and then at 48hrs 
after the initial injury, mice underwent the same surgical procedures except for the absence 
of craniotomy, and then received the same lateral fluid percussion injury (details can be found 
in Chapter 2). The time interval of 48 hrs between mild CCI injuries has been used in adult 
mice to replicate repetitive brain injuries (Mouzon et al., 2012, Ojo et al., 2013). In the current 
study, 48 hrs injury interval was chosen as it is a temporal window during which the secondary 
injury is still existing and the mouse brain is susceptible to later injuries (Longhi et al., 2005). 
Additionally, this injury interval was selected in order to mimic injuries in patients, in which 
additional injuries are sustained prior to full recovery from the previous injury. Further 
investigations where this interval is both increased and decreased would likely reveal 
interesting insights, but were beyond the scope of this study. Finally, mice were perfused at 
either 1 week or 4 weeks post initial injury. Mice were randomized to 1 week (n=6) and 4 
weeks (n=4) injured group. Details regarding immunohistochemistry protocols can be found 





5.3.1. mTBI resulted in significant cortical thinning at 4 weeks post injury in female mice 
but not male mice 
TBI in the mouse is considered ‘mild’ if the mortality rate after experimental injury is between 
0 and 5%, a righting reflex occurs within 2 and 4 minutes and the loss of consciousness is 
less than 2 minutes (Morehead et al., 1994, Alder et al., 2011). In the present study, no 
mortality was observed, and the LFPI was associated with a short duration of apnoea (Fig 5.1 
B). The duration of apnoea did not differ between male and female injured mice (p=0.8725). 
In regard to the righting reflex time (Fig 5.1 C), two-way ANOVA revealed no significant 
interaction between sex and injury (F1,42 =0.1824, p=0.6715). However, as expected, the loss 
of consciousness was significantly increased in brain-injured mice in comparison to sham-
operated mice in both males (p<0.0001) and females (p<0.0001). With regards to the measure 
of cortical thickness (Fig 5.1 D), an ordinary three-way ANOVA found a significant interaction 
between sex and the time post-injury (F1,41 =4.773, p=0.0347). Tukey’s multiple comparison 
tests found multiple significant differences. The cortical thickness was thinner in female sham-
operated mice compared to male sham-operated mice at 1 week post injury (p=0.0383). 
Additionally, the cortical thickness in the cohort of female brain injured mice was significantly 
thinner compared to male brain injured mice at both 1 week and 4 weeks post injury (p=0.0005, 
p<0.0001, respectively). Furthermore, the injury resulted in a significantly decreased cortical 
thickness at 4 weeks post-injury compared to sham-operated mice in females (p=0.0004). In 
regard to the YFP positive cell density (Fig 5.1 E) and the cell soma size (Fig 5.1 F), an 
ordinary three-way ANOVA revealed no significant interaction between sex and the time post 




Figure 5.1. Cortical thickness was reduced in females at 4 weeks post injury 
compared to sham injured animals but was unchanged in males. 
 
Representative image of LFPI in an female Thy1-YFPH mouse brain (A). LFPI induced 
duration of apnoea did not differ between male and female brain-injured mice (B). LFPI 
induced loss of consciousness was not different between male and female brain-injured 
mice (C). The cortical thickness did not change after injury compared to shams in males, but 
was significantly decreased at 4 weeks post injury in female brain-injured mice compared to 
shams. Additionally, the cortical thickness in sham-operated and brain-injured mice was 
reduced in female compared to male mice at 1 week post injury. Furthermore, the cortical 
thickness in sham mice was thinner in female compared to male mice at 4 weeks post injury 
(D). The YFP positive cell density (E) and the cell soma size (F) in the cortex did not change 
at either 1 week or 4 weeks post mild injury compared to shams in both male and female 
mice. Data are presented as mean ± SEM. Three-way ANOVA, followed by Turkey’s test 




5.3.2. Glial response after mTBI is distinctive in male and female mice 
The consequence of mTBI on GFAP immunoreactivity was investigated within the neocortical 
region of the injury site (experimental details can be found in Chapter 2). In regards to 
astrocyte activation (Fig 5.2 C), an ordinary three-way ANOVA revealed no significant 
interaction between sex and the time post injury (F1,39 =0.8839, p=0.3529). Astrocytic 
activation was not significantly different between males and females in either sham operated 
or brain injured cohorts. Furthermore, astrocyte activation was significantly increased at 1 
week post injury in brain-injured mice in comparison to sham-operated mice in females 
(p=0.0011). Overall, this data indicates that astrocyte activation was similar between males 
and females in both sham operated and brain injured cohorts, and the injury resulted in higher 
astrocytic activation only in females at 1 week post injury and resolved by 4 weeks post injury. 
 
The consequence of mTBI on Iba1 immunoreactivity was investigated within the same region 
of analysis as GFAP (experimental details can be found in Chapter 2). As to microglial 
activation (Fig 5.2 D), an ordinary three-way ANOVA revealed no significant interaction 
between sex and the time post injury (F3,40 =0.1008, p=0.9591). The microglial activation was 
significantly higher in females compared to males in both sham operated (p=0.0091, p=0.0071 
respectively) and brain-injured (p=0.0218, p=0.0025 respectively) cohorts. Furthermore, 
microglial activation was significantly increased at 1 week post injury in brain-injured mice 
compared to sham-operated mice in male cohorts (p=0.0383). Overall, this data suggests 
microglial activation in sham operated mice and brain injured mice was higher in female cohort 
compared to male cohorts. And the injury induced microglial activation only at 1 week post 




Figure 5.2. Distinctive glial response after mTBI in male and female mice. 
 
Representative image of mTBI on astrocyte (A) and microglia (B) in the neocortex. In the 
neocortex, astrocyte activation was increased at 1 week post injury in brain-injured mice 
compared to sham-operated mice in females. This activation resolved by 4 weeks post injury 
(C). The microglial activation was significantly higher in female cohorts compared to male 
cohorts. Furthermore, microglial activation was increased at 1 week post injury in brain-
injured mice in comparison to sham-operated mice in males, and this activation resolved by 
4 weeks post injury (D). Data are presented as mean ± SEM. Three-way ANOVA, followed 









5.3.3. mTBI induced axonal degeneration resolves earlier in female mice but excerbates 
in male mice 
In the current study, axonal degeneration related analysis was investigated in the internal 
capsule white matter tracts. The amount of axonal degeneration was quantified as a 
percentage of total area (Fig 5.3 B), an ordinary three-way ANOVA revealed a significant 
interaction between sex and the time post injury (F3,37 =7.360, p=0.0005). Tukey’s multiple 
comparisons tests identified multiple significant differences. The degree of axonal 
degeneration at 4 weeks post injury in brain injured mice was significantly higher in male brain 
injured mice compared female brain injured mice (p=0.0002), and was also higher in 
comparison to male brain injured mice at 1 week post injury (p=0.0157). Furthermore, the 
axonal degeneration was significantly higher at both 1 week post injury in both males and 
females brain-injured animals compared to the corresponding sham-operated mice 
(p=0.0019, p<0.0001 respectively), those was also observed at 4 weeks post injury in both 
males and females brain-injured mice compared to the corresponding sham-operated mice 
(p<0.0001, p=0.0139 respectively).  
 
When considering the number of axonal fragments (Fig 5.3 C), an ordinary three-way ANOVA 
found a significant interaction between sex and the time post injury (F1,37 =8.968, p=0.0049). 
Tukey’s multiple comparisons tests identified multiple significant differences. The relative 
number of axonal fragments in female brain injured mice was significantly decreased from 1 
week post injury to 4 weeks post injury (p=0.0050). Furthermore, the relative number of axonal 
fragments was significantly higher at 1 week post injury in both male and female brain-injured 
mice compared to the corresponding sham-operated mice (p=0.0481, p<0.0001 respectively), 
those was also observed at 4 weeks post injury in both males and females brain-injured mice 
compared to the corresponding sham-operated mice (p=0.0104, p=0.0039 respectively).  
 
Finally, an analysis of the size of axon fragments (Fig 5.3 D) was performed. An ordinary 
three-way ANOVA found no significant interaction between sex and the time post injury (F1,37 
=1.934, p=0.1726). The size of axon fragments was not significantly different between males 
and females in either sham operated or brain injured mice. Furthermore, the size of axonal 
fragments was significantly increased at 1 week post injury in brain-injured mice compared to 
sham-operated mice in females (p<0.0001). Additionally, the size of axonal fragments was 
significantly lower at 4 weeks post injury compared to 1 week post injury in brain-injured mice 
of females (p<0.0013).  
 
Overall, this data suggests mTBI induced higher axonal degeneration in both male and female 
mice compared to sham operated mice at both 1 week and 4 weeks post injury. Furthermore, 
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sex dependent axonal degeneration after mTBI was also observed. While injured induced 




Figure 5.3. Axonal degeneration after injury resolves in females but excerbates in 
males. 
Representative images of YFP expressing axons in the internal capsule in the Thy1-YFPH 
transgenic mouse brain (A). The percentage of axonal degeneration in the internal capsule 
was higher at both 1 week and 4 weeks post-injury in both male and female brain injured 
mice compared to sham operated mice, moreover, the percentage of axonal degeneration at 
4 weeks post injury in male brain injured mice, compared to 1 week post injury in male brain 
injured mice and incomparison to 4 weeks post injury in female brain injured mice (B). The 
relative number of axon fragments was increased at both 1 week and 4 weeks post-injury in 
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both male and female brain injured mice compared to sham operated mice, furthermore, the 
relative number was significantly higher in female brain injured mice at 1 week post injury 
compared to 4 weeks post injury (C). The size of axon fragments was increased at 1 week 
post-injury in both male and female brain injured mice in comparison to sham operated mice. 
Furthermore, the size of axon fragments was higher in female brain injured mice at 1 week 
post injury compared to 4 weeks post injury (D). Data are presented as mean ± SEM. Three-




5.3.4. Spine density after mTBI was comparable between male and female mice 
In the present study, there was no significant difference between total spine density in injured 
animals compared to shams in either male or female cohorts, at either 1 week or 4 weeks post 
injury (Fig 5.4 A; F1,41 =0.06324, p=0.8027). Similarly for each individual morphological 
subtype, there were no significant interactions between spines density, sex and time post 
injury for thin (Fig 5.4 B; F1,42 =0.5107, p=0.4788), stubby (Fig 5.4 C; F1,41 =0.3119, p=0.5796), 
or mushroom (Fig 5.4 D; F1,41 =0.8388, p=0.3651) spines. Overall, total spine density and 
specific morphological sub-class spine density did not differ between male and female mice 






Figure 5.4. Spine density changes after injury are independent of sex. 
 
There was no significant difference between the total spine density (A), or the density of thin 
(B), stubby (C) and mushroom (D) spines in injured animals compared to shams in either the 
male and female cohorts, at either 1 week or 4 weeks post injury. Data are presented as 
mean ± SEM. Three-way ANOVA, followed by Turkey’s tests. 
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5.3.5. Repetitive mTBI resulted in significantly reduced cortical thickness compared to 
single injury  
In the current study, no mortalities were observed in either single injured or repetitive injured 
animals, but a short time of apnoea (Fig 5.5 A) and a delay in the righting reflex time (Fig 5.2 
B) were observed after mTBI. In regard to the duration of apnoea and the righting reflex time 
(Fig 5.5 A and B), an unpaired t-test found the duration of apnoea and unconsciousness was 
not significantly different after the second injury compared to the first injury (p=0.0792, 
p=0.1133 respectively). As to the cortical thickness (Fig 5.5 C), a two-way ANOVA revealed 
no significant interaction between number of injuries and the time post injury (F1,19 =0.06733, 
p=0.7981). However, the cortical thickness was significantly decreased after repetitive injuries 
(2 injuries at 48 hrs apart) compared to a single mild injury (p=0.0038). As to the YFP positive 
cell density (Fig 5.5 D) and the cell soma size (Fig 5.5 E), two-way ANOVA revealed no 
significantly interaction between number of injuries and the time post injury (F1,19 =0.7014, 
p=0.4127; F1,19 =1.441, p=0.2447).  
 
Figure 5.5. Repetitive injury significantly decreased cortical thickness without overt 
neuronal degeneration compared to a single injury. 
LFPI induced duration of apnoea (A) and righting reflex time (B) did not differ after the 
second injury compared to the first injury. Repetitive injury (two injuries at 48 hours apart) 
significantly decreased the thickness of neocortex at both 1 week and 4 weeks post injury 
compared to a single mild injury (C). An additional injury at 48 hours after the initial injury did 
not change the YFP positive cell density in the neocortex at either 1 week or 4 weeks post 
injury in comparison to a single mild injury (D). An additional injury at 48 hours after the initial 
injury did not alter the YFP positive cell soma size in the neocortex at either 1 week or 4 
weeks post injury compared to a single mild injury (E). Data are presented as mean ± SEM. 
Two-way ANOVA, followed by Tukey’s tests **p<0.01. 
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5.3.6. Repetitive mTBI resulted significantly increased glial activation in comparison to 
single injury 
The consequence of repetitive injuries (two injuries at 48hrs apart) on GFAP immunoreactivity 
was investigated within the neocortical region of the injury site (experimental details can be 
found in Chapter 2). With regard to astrocyte activation (Fig 5.6 C), a two-way ANOVA 
revealed a significant interaction between the number of injuries and the time post injury (F1,19 
=7.013, p=0.0159). Repetitive injuries significantly increased astrocytic activation at 1 week 
post injury in comparison to a single injury (p=0.0060). The astrocyte activation in mice that 
received repetitive injuries was significantly reduced at 4 week post injury compared to 1 week 
post injury (p<0.0001), similarly, after a single injury, the astrocytic activation was significantly 
decreased at 4 weeks post injury compared to 1 weeks post injury (p=0.0457). The 
consequence of repetitive injuries on Iba1 immunoreactivity was also investigated within the 
same region of analysis as GFAP (experimental details can be found in Chapter 2). As to the 
microglial activation (Fig 5.6 D), a two-way ANOVA revealed no interaction between the 
number of injuries and the time post injury (F1,20 =1.151, p=0.2961). However, multiple 
comparisons showed repetitive injuries significantly increased microglial activation at 4 weeks 
post injury in comparison to a single mild injury (p=0.0032). Additionally, the microglial 
activation in mice that received a single injury was significantly decreased at 4 weeks post 
injury compared to 1 week post injury (p=0.0174). Overall, compared to a single injury, 
repetitive injuries significantly increased astrocytic activation at 1 week post injury and 




Figure 5.6. Repetitive injury significantly increased astrocytic and microglial 
activation compared to a single injury. 
 
Representative image of repetitive injury (two injuries at 48 hours apart) on astrocyte (A) and 
microglia (B) in the neocortex. Repetitive injuries significantly exacerbated astrocytic 
activation in the injured neocortex at 1 week post injury in comparison to a single mild injury 
(C). An additional injury at 48 hours after the initial injury significantly exacerbated microglial 
activation at 4 weeks post injury in the injured neocortex in comparison to a single mild injury 
(D). Data are presented as mean ± SEM. Two-way ANOVA, followed by Tukey’s tests 




5.3.7. Repetitive mTBI resulted in significantly exacerbated axonal degeneration in 
comparison to a single injury 
In the present study, analysis of the percentage area of axonal degeneration (Fig 5.7 B) by 
two-way ANOVA revealed no significant interaction between the number of injuries and the 
time post injury (F1,15 =0.7062, p=0.4139). The axonal degeneration was significantly 
increased after repetitive injuries (2 injuries at 48 hrs apart) in comparison to a single mild 
injury at 1 week post injury (p=0.0079). In regard to the relative number of axon fragments 
(Fig 5.7 C), a two-way ANOVA revealed no significant interaction between number of injuries 
and the time post injury (F1,15 =0.6817, p=0.4219). Finally, in regard to the size of axon 
fragments (Fig 5.7 D), a two-way ANOVA revealed no significant interaction between number 
of injuries and the time post injury (F1,15 =3.200, p=0.0938). However, the axonal fragment size 
was significantly increased after repetitive injuries compared to a single mild injury at both 1 







Figure 5.7. Repetitive injuries significantly exacerbated axonal degeneration 
compared to a single injury. 
 
Representative images of YFP expressing axons in the internal capsule of the Thy1-YFPH 
transgenic mouse brain (A). Repetitive injury (two injuries at 48 hours apart) significantly 
increased the percentage area of axonal degeneration in the internal capsule at 1 week post 
injury but not at 4 weeks post injury in comparison to a single mild injury (B). A second injury 
at 48 hours after the initial injury significantly increased the number of axonal fragments at 
both 1 week and 4 weeks post injury in comparison to a single mild injury (C). A second 
injury at 48 hours after the initial injury did not change the size of axonal fragments in the 
internal capsule at either 1 week or 4 weeks post injury in comparison to a single mild injury 
(D). Data are presented as mean ± SEM. Unpaired t-test, **p<0.01, ***p<0.001. Scale 
bar=40um. 
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5.3.8. Repetitive mTBI did not change spine density compared to a single injury  
In the present study, there was no significant difference between total spine density in 
repetitive injured (2 injuries at 48 hrs apart) animals compared to single injured animals, at 
either 1 week or 4 weeks post injury (Fig 5.8 A; F1,19 =0.1944, p=0.6643). Similarly for each 
individual morphological spine subtypes, there was no significant interaction between spine 
density, injury numbers and the time post injury for thin (Fig 5.8 B; F1,19 =0.008780, p=0.9263), 
stubby (Fig 5.8 C; F1,19 =0.1951, p=0.6637), or mushroom (Fig 5.8 D; F1,19 =0.5200, p=0.4796) 
spines. Overall, repetitive brain injury did not change the total spine density or sub-class 




Figure 5.8. Repetitive injury did not affect the density of total spines or the individual 
sub-classes of spines compared to a single injury. 
 
No significant changes between the total spine density (A), as well as the density of thin (B), 
stubby (C) and mushroom (D) spines after repetitive injuries (two injuries at 48 hours apart) 
compared to a single mild injury at either 1 week or 4 weeks post injury. Data are presented 







Males are reported as having a higher possibility of sustaining TBI than females during their 
lifespan (Rickels et al., 2010), however, females have been reported with a 1.4 times higher 
incidence of concussion than males in some sports activities (Covassin et al., 2016). 
Outcomes after brain injuries between sexes are complicated and inconsistent, with most 
clinical studies showing females having poorer outcomes following TBI, including mild severity 
injuries, while a number of experimental studies suggest females may have reduced negative 
outcomes (Wagner et al., 2004, Bruce-Keller et al., 2007, Dick, 2009, Preiss-Farzanegan et 
al., 2009, Bazarian et al., 2010, Cantu et al., 2010, Frommer et al., 2011, Laker, 2011, 
Covassin and Bay, 2012). Therefore, investigating sub-cellular reactions following mild injury 
in animals may help us understand how sex can influence outcomes following mild TBI.  
 
Repetitive mTBI (rmTBI) has been associated with neurophysiological changes, cognitive 
impairments, and the development of neuronal degenerative diseases in later life (including 
AD and CTE) (Luo et al., 2014, Nordström et al., 2014, Vynorius et al., 2016, Multani et al., 
2016, Montenigro et al., 2017, Merritt et al., 2018). Compelling studies have tried to replicate 
the biomechanical, neurological and pathological changes of rmTBI patients, with inconsistent 
number of injuries and intervals between injuries used. Thus, additional studies on repetitive 
mild injured are also needed. The final chapter of this thesis, presents two further 
investigations of potential risk factors for mTBI, sex and a subsequent second injury.   
 
In the present study, using a mild LFPI model in both males and females, we observed a 
thinner cortex without overt neuron loss in females compared to males. Additionally, the glia 
showed distinctive activation pattern after mild injury between male and female mice, however, 
axonal degeneration after mTBI is initiated at short-term in both sex, and later on, excerbated 
in males but partially resolved in females. Furthermore, we found repetitive injury (two injuries 
at 48 hrs apart) significanlty increased astrocytic activation at 1 week after injury and microglial 
activation at 4 weeks post injury. Additionally, repetitive injury  also reduced cortical thickness 
and exacerbated axonal degeneration at 4 weeks post injury compared to a single mild injury. 
Thus it appears that repetitive injury, 48 hours apart, exacerbates cellular and subcellular 
pathology. 
 
The lateral fluid percussion injury model has been widely used to mimic clinical mTBI 
pathologies (Spain et al., 2010, Alder et al., 2011, Shultz et al., 2011, Wright et al., 2016, 
Powell et al., 2018). In both clinical and preclinical studies,  a TBI is considered mild if it occurs 
in the absence of overt cortical loss and cavitation (Iverson et al., 2010, Gao and Chen, 2011, 
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Meconi et al., 2018). Additionally, it has also been suggested that the mortality rate after 
experimental mild injury should be between 0 and 5%, with a righting reflex within 2 and 4 
minutes and a loss of consciousness of less than 2 minutes (Morehead et al., 1994, Alder et 
al., 2011, Teng and Molina, 2014, Katz et al., 2015). In the current study, mortality, loss of 
consciousness and righting reflex results validated that the injury in our study was mild in 
severity. It has been reported that the duration of apnoea and righting reflex time was not 
significantly different between male rats and female rats following moderate TBI (Avcu et al., 
2019, Newell et al., 2019, Saber et al., 2019). Similarly, in the current study, the duration of 
apnoea and righting reflex time was comparable between female and male brain-injured mice, 
thus providing further evidence for support of the use of the lateral fluid percussion injury 
model in both sexes of mice in future studies. 
 
In order to investigate the discrepancies in the literature between clinical and pre-clinical 
studies in regard to the effect of sex and also the effect of an additional injury on mTBI 
outcomes, we firstly investigated the neuronal population. Absence of overt neuronal loss after 
mTBI has been widely observed in male brain injured mice (Iverson et al., 2010, Gao and 
Chen, 2011, Meconi et al., 2018). Similar to a recent previous study (Velosky et al., 2017), we 
found female sham mice had reduced cortical thickness compared to male sham mice. A study 
by Wright and colleagues reported reduced thickness of the prefrontal cortex at 7 days after 
multiple mTBIs in female rats (Wright et al., 2018). Additionally, it has also been reported that 
higher hemispheric volume loss was detected at 21 days but not at 1 day after moderate to 
severe TBI in both male and female mice (Newell et al., 2019). In the present study, we found 
that mild injury did not change cortical thickness at 1 week post injury, however it significantly 
decreased cortical thickness at 4 weeks post-injury compared to shams in female mice, which 
was not observed in male mice. Additionally, the YFP positive cell density and soma size did 
not change after injury in either female or male mice. Thus, it may suggest mTBI in female 
mice may result in later onset decrease in the cortical thickness but without overt changes in 
pyramidal neurons.  
 
With regard to repetitive mTBI (rmTBI), a number of previous studies have reported no overt 
structural abnormalities or neuronal loss after rmTBI (Huang et al., 2013, Weil et al., 2014, 
Winston et al., 2016, Xu et al., 2016, Effgen and Morrison, 2017, Robinson et al., 2017, Gold 
et al., 2018, Meconi et al., 2018), whereas others report hemorrhagic lesions and degenerating 
cells at short term as well as longer term timer points after rmTBI (Aungst et al., 2014, Bolton 
and Saatman, 2014). In the present study, we found repetitive mild injuries (an additional injury 
at 48 hours intervals) resulted in a significantly reduced cortical thickness relative to a single 
mild injury at both 1 week and 4 weeks post injury. This suggests that a second injury at 48 
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hours after the initical injury caused severe damage to the neocortex. One study reported 
rmTBI (5 injuries at 48 hours intervals) caused comparable neurodegeneration to those of a 
single mild injury at 9 days post injury (Bolton and Saatman, 2014). Similarly, we observed 
that the repetitive injury did not change the YPF positive cell density and cell soma size in the 
cortex compared to a single mild injury, suggesting no overt pyramidal neuron loss in the 
cortex after repetitive injury. Overall, our studies further supported that a second injury at 48 
hours intervals significantly reduced cortical thickness without overt changes in pyramidal 
neuronal populations compared to a single mild injury. 
 
Next, we investigated the effect of sex and an additional injury on the glial reaction after mTBI. 
Increased levels of GFAP and Iba-1 are an indication of reactive astrogliosis and microgliosis 
respectively (Liedtke et al., 1996, Ito et al., 1998). According to the literature of mTBI, higher 
astrocytic and microglial activation have been observed at both short term and long term time 
points after brain injury (Shultz et al., 2013, Huang et al., 2014, Goodrich et al., 2016, 
Rodriguez-Grande et al., 2018). Glial activation plays an important role in both promoting and 
preventing the recovery from brain injury (Womble and Moises, 1993, Hamlin et al., 2001, 
Bayir et al., 2007, Wu et al., 2009, Pun et al., 2010, Burda et al., 2016, Loane and Kumar, 
2016). It has been reported that astrocyte activation is higher in female mice at 1 day post 
moderate TBI compared to shams and male brain injured mice, but this difference was not 
observed at 7 days post-injury (Jullienne et al., 2018). However, other investigations have 
reported that astrocytes activation is higher in males compared to females at 7 days after 
injury, but not at 30 days, in the cortex, and that this sex related difference was not observed 
in the dentate gyrus (Villapol et al., 2017). In the current study, we found there was higher 
astrocytic activation in the somatosensory cortex at 1 week post-injury in brain injured mice 
compared to sham operated mice in female cohorts. Moreover, this injury related astrocytic 
activation resolved at 4 weeks post-injury. Our results suggest male and female mice showed 
different patterns of astrocytic activation after mild TBI. In an investigation using the controlled 
cortical impact model of injury, it has been reported that microglial activation is higher in both 
male and female mice at 7 days but not at 1 day post moderate TBI compared to shams, and 
is not sex dependent (Jullienne et al., 2018). Moreover, it is also reported that a moderate-
severe TBI increased microglial activation in the cortex among both male and female mice at 
1 day post injury but not at 21 days post injury and was not sex dependent (Newell et al., 
2019). Furthermore, another study found microglial activation after a moderate to severe TBI 
in the cortex was not different between male and female brain-injured mice at either 7 days 
post injury or 30 days post injury (Villapol et al., 2017). In the current study, we found there 
was higher microglial activation in the injured cortex at 1 week post-injury compared to sham 
mice in male mice. Moreover, the microglial activation in sham operated mice and brain injured 
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mice was higher in female in comparison to male cohorts. Cumulatively, this data suggests 
that male and female mice showed distinct patterns of astrocytic and microglial activation after 
mild TBI. 
 
In terms of rmTBI, widespread astrogliosis has been observed at both short and long term 
post-injury time points, and at multiple sites including the cortex, corpus callosum and 
hippocampus (Luo et al., 2014, Yang et al., 2015, Xu et al., 2016, Chen et al., 2017, Effgen 
and Morrison, 2017, Robinson et al., 2017, Cheng et al., 2019). Furthermore, widespread Iba-
1 positive cells have been reported in multiple sites both at short term and long term after 
rmTBI in the cortex, optic tract and the external capsule (Bolton and Saatman, 2014, Fidan et 
al., 2016, Winston et al., 2016, Xu et al., 2016, Chen et al., 2017, Effgen and Morrison, 2017, 
Robinson et al., 2017, Cheng et al., 2019). Similarly, in the current study, we observed that 
repetitive mild injuries (an additional injury at 48hrs post initial injury) significantly increased 
astrocytic at 1 week post injury and microglial activation at 4 weeks post injury in the injured 
cortex compared to a single mild injury. Furthermore, Bolton and Saatman reported that rmTBI 
(5 injuries at 48hrs intervals) caused comparable astrocytic activation to those of a single mild 
injury at 9 days post injury (Bolton and Saatman, 2014). In the current study, we observed 
both that the astrocytic activation after rmTBI was similar to those of a single mild injury at 4 
weeks post injury.  
 
Numerous studies have reported dendritic changes, including dendrite loss and degeneration 
and changes to spine turn over, after mTBI (Cahill et al., 2016, Gao and Chen, 2011, Sword 
et al., 2013, Chen et al., 2018, Zhao et al., 2018). In one study, it was reported that there was 
no difference in dendritic spine density between sexes at 20 days after mTBI in juvenile (P30) 
rats (Mychasiuk et al., 2015b). However, others found the spine density was not different 
between sexes in juvenile (P48) sham operated mice, but the total spines density in the 
mediate medial prefrontal cortex as higher in brain injured mice at 17 days after injury (using 
closed head weight drop model) in females than males (Hehar et al., 2015). In present study, 
we found there was no difference in total spine density and sub-class specific of spine density 
between male and females and between injury and shams. The discrepancy may due to the 
method used - Hehar and colleague used a modified close head weight drop injury model and 
applied Golgi-Cox straining for quantification. With regard to rmTBI, studies report repetitive 
injuries exacerbated dendritic degeneration and loss, as well as spine density reduction (Ojo 
et al., 2015, Effgen and Morrison, 2017, Algamal et al., 2019). In the current study, we did not 
observe any significant changes in total spine density and subclass spine densities after an 
additional injury at 48 hours compared to a single mild injury. The discrepancy may due to the 
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method of quantitation used, as Golgi-Cox Staining and electron microscopy was used in other 
studies (Ojo et al., 2015, Algamal et al., 2019).  
 
Lastly, we investigated the axonal responses after mTBI, relative to sex and the proposed risk 
factor of an additional injury. Diffuse axonal injury is a pathological hallmark of mTBI. It has 
been suggested that axon impairments with transport disruption, organelle accumulation, 
axonal swelling, bulb formation and degeneration following mTBI are associated with the 
behavioural and cognitive deficits after brain injury (Carmona et al., 2010, Greer et al., 2013, 
Mierzwa et al., 2015, Henninger et al., 2016, Chen et al., 2018, Chuckowree et al., 2018). 
However, studies of axonal pathology after injury have been mainly conducted in male animals 
while female animals are less well investigated. In an in vitro model of traumatic axonal injury 
(TAI) in neurons derived from both rat primary cortical neurons and human induced Pluripotent 
Stem Cells (iPSC), it was reported that the stretch injury induced significantly more swellings 
and increased loss of calcium signaling function in axons derived from female rat primary 
cortical neurons and female differentiated iPSC compared to males at 24 hours post-injury 
(Dollé et al., 2018). Moreover, it is reported by Newell and colleagues, a moderate to severe 
TBI in juvenile mice (21±3 days) resulted in a significant increase in the percentage area of 
βAPP in the corpus callosum and external capsule at both 1 day and 21 days post injury but 
this result was not different between male and female brain-injured mice (Newell et al., 2019). 
In the current study, we observed that mTBI significantly increased axonal degeneration at 
both 1 week and 4 weeks post injury in both male and female cohorts. However, sex 
dependent axonal degeneration was also indicted. Increased axonal degeneration was 
observed at 4 weeks post injury in males compared to females brain injured mice. Moreover 
higher axonal degeneration in male brain injured mice at 4 weeks post injury was found 
compared to 1 week post injury, while less fragment number and smaller fragment size were 
observed in female brain injured mice at 4 weeks post injury in comparison to 1 week post 
injury. Overall, our findings suggest that axonal degeneration after mTBI initates at 1 week 
post injury in both male and female cohorts, while at later timepoint, resolved earlier in female 
cohorts but excerbated in male cohorts. 
 
In regard to rmTBI, axonal pathology has also been widely reported, which may partially 
contribute to injury-related behavioural and cognitive deficits (Fujita et al., 2012, Hylin et al., 
2013, Bennett and Brody, 2014, Bolton and Saatman, 2014, Luo et al., 2014, Mouzon et al., 
2014, Fidan et al., 2016, Chen et al., 2017, Cheng et al., 2019, Cross et al., 2019). It has been 
reported that the axonal damage detected by APP immunolabeling was more predominant 
with shorter intervals between injuries (3 hours and 24 hours intervals) (Fujita et al., 2012, 
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Bolton and Saatman, 2014). Additionally, it has also been reported that rmTBI induced 
increased phosphorylation of tau, and axonal argyrophilia in the external capsule and corpus 
callosum compared at 1 week post injury (Fidan et al., 2016, Tan et al., 2016). In the current 
study, we observed that axonal degeneration in the internal capsule is increased at 1 week 
but not at 4 weeks post repetitive injury (two injuries at 48hrs apart) compared to a single 
injury. Additionally, axonal fragment number was higher at both 1 week and 4 weeks post 
repetitive injury in comparison to a single mild injury. Therefore, it indicates that the second 
injury significantly exacerbated the axonal degeneration in the internal capsule at both 1 week 
and 4 weeks post injury. Our findings contrast with those of Bolton and colleagues (Bolton and 
Saatman, 2014). In their study, they applied 5 mild closed head injuries at 48 hours apart, and 
they found the pathological outcomes at 9 days after the initial injury after 5 injuries was 
comparable to a single mild injury (Bolton and Saatman, 2014). The discrepancy between our 
findings and Bolton and colleagues’ findings is possibly due to the model used. In the current 
study we used an open head mild injury model, whereas Bolton and colleagues applied a 
closed head mild injury model. This may suggest that repetitive injury (two injuries at 48 hours 
intervals) initiated axonal pathological changes earlier and persisted longer in the internal 
capsule white matter tracts. However, future studies including repetitive sham operated mice 
are needed in order to verify this. 
 
To conclude, in the present study, we found that glial responses to trauma were sex 
dependent. Additionally, axonal degeneration in the cortex triggered by mild traumatic brain 
injury was sex dependent with the degeneration initiated at short-term in both male and female 
cohorts, resolved quicker in females but excerbated in males. Additionally, we provide further 
evidence supporting previous findings that repetitive injury (two injuries at 48hrs apart) 
significantly exacerbates cellular and sub-cellular pathologies, with increased astrocytic 
activation short-term after injury and microglial activation long-term after injury, as well as 
decreased cortical thickness and increased axonal degeneration at both 1 week post injury in 
comparison to a single brain injury. Therefore, more attention and monitoring are needed for  





mTBI, accounting for more than 80% of TBI cases (Luo et al., 2017), is a serious public health 
issue (Gardner and Yaffe, 2015). According to the Centers for Disease Control and Prevention 
(CDC), children aged under 4 years, adolescents aged between 15 and 19 years, together 
with older aged people over 75 years have high incidence rates of TBI (Laskowitz and Grant, 
2016). With a growing ageing population, the number of aged TBI cases is increasing. 
Previous studies have reported that being older in age at the time of injury is associated with 
higher mortality and morbidity, as well as increased behavioural and cognitive impairments. 
However, in the context of mTBI, the influence of age at the time of injury on the outcomes 
following injury is less well investigated and the underlying cellular changes are less well 
studied. Whilst the therapeutic potential of epothilone D in mTBI has been investigated in both 
in vitro and in vivo studies, whether there exists an age dependent effect of epothilone D has 
not been well studied. Previous studies have reported that there are differences related to sex 
not only in the incidence but also in the recovery processes that occur after brain injury 
(Hillbom and Holm, 1986, Hirtz et al., 2007). However, with regard to mTBI, the influence of 
sex on the cellular reaction is less well studied. Furthermore, various parameters, such as the 
number of injuries and the interval between injuries, have been investigated in models of 
repetitive mTBI (Cheng et al., 2014a, Selwyn et al., 2016, Multani et al., 2016, Ferguson et 
al., 2017a, Merritt et al., 2018), however, the reports regarding the resulting cellular and 
subcellular changes are still inconclusive and inconsistent.  
 
The outcomes and recovery processes following mTBI are heterogeneous, this is partially due 
to the interplay of various risk factors. Thus, this thesis using lateral fluid percussion injury, 
focused on the neuronal and glial reactions after injury to provide insights into the cellular and 
subcellular responses to mTBI in the brain. The hypothesis of this thesis was that cellular and 
subcellular responses to mTBI, of both neuronal and glial populations, vary greatly depending 
on a variety risk factors, including age at injury, post-injury time interval, sex, repetition of injury 
and duration between injuries. In order to address the hypothesis, this thesis investigated four 
aims. In Aim 1, to determine the effect of age on the cellular reactions after mTBI in a mouse 
model, a mild lateral fluid percussion injury was performed in young (1.5 months), adult (3 
months) and aged (12 months) mice, with cellular and subcellular responses compared 
between brain injured mice and sham operated mice, as well as between different aged mice 
(Chapter 3). Then to extend upon the findings of Aim 1, and determine the age dependent 
therapeutic potential of the microtubule stabilizing agent epothilone D following mTBI in young 
(1.5 months) and adult (3 months) mice, as described in Aim 2 of this thesis, the effect of 
epothilone D or vehicle treatment was measured by neuronal and glial reactions following 
 86 
mTBI in both young and adult cohorts (Chapter 4). Finally, two studies investigated how the 
potential risk factors, sex (Aim 3) and an additional injury (Aim 4), influence the cellular and 
subcellular reactions after mild lateral fluid percussion in a mouse model (Chapter 5). 
 
We found that the risk factors, age at injury, sex and additional injury, consistently did not 
differentially affect the duration of apnoea or the period of unconsciousness after mTBI. 
Additionally, these factors did not differentially influence the pyramidal neuronal population, 
with regard to pyramidal cell number or cell soma size, in the neocortex at either 1 week or 4 
weeks post injury. Furthermore, these factors did not differentially affect the density of total 
dendritic spines or specific sub-classes of spines at either 1 week or 4 weeks post injury.  
 
It was, however, found that these three risk factors differentially affected the axonal response 
after mTBI. With regard to the age at injury, injury induced axonal degeneration in the internal 
capsule was found to be age dependent. Whilst axonal degeneration was observed at 1 week 
post injury but resolved at 4 weeks post injury in young brain injured mice, it was observed at 
both 1 week and 4 weeks post injury in both adult and aged brain injured cohorts. Additionally, 
axonal degeneration at 4 weeks post injury in the internal capsule was higher in both adult 
and aged brain injured mice compared to young brain injured mice (summarized in Fig 6.1). 
Furthermore, the effect of epothilone D treatment on axonal degeneration after injury was age 
dependent, with no significant positive or negative effect in the young brain injured mice, but 
significantly exacerbated axonal degeneration in adult brain injured mice compared to vehicle 
treated animals (summarized in Fig 6.2). As to the influence of sex, we found that mTBI 
induced axonal degeneration initiated at short term both in male and female cohort, and was 
partially resolved in females while was excerbated in males at long term after injury 
(summarized in Fig 6.3). Finally, with regard to the influence of an additional injury, we found 
that repetitive injury (two injuries at 48hrs apart) significantly exacerbated axonal degeneration 



























































Age at injury, sex and and an additional injury were also found to differentially influence the 
glial response to mTBI. With regard to the influence of the age at injury, glial activation was 
age dependent, with higher astrocyte activation in young brain injured mice but not in either 
adult or aged brain injured mice. Additionally, mTBI increased microglial activation in adult 
brain injured mice but not in young or aged brain injured mice compared to their sham 
operated counterparts, the microglial activation in both sham operated and brain injured was 
higher in aged mice compared to younger mice (summarized in Fig 6.1). With regard to the 
influence of sex, we found that mTBI induced astrocyte activation was dependent of sex, with 
injury induced higher astrocyte activation at 1 week post injury in female but not in male cohort. 
Additionally, microglial activation was also found to be dependent of sex. Microglial activation 
was higher in male but not in female brain injured mice compared to sham operated mice at 
1 week post injury, and the microglial activation in both sham operated and brain injured was 
higher in female cohorts compared to male cohorts (summarized in Fig 6.3). Finally, 
investigations of the influence of an additional injury found that repetitive injury significantly 
increased astrocytic activation at 1 week post injury and microglial activation at 4 weeks post 
injury in comparison to a single mild injury (summarized in Fig 6.4). 
We did not find any differential influence of the age at injury on the cortical thickness. However, 
with regard to the influence of sex, we found that the cortical thickness in female brains was 
thinner compared to male mice brains, and the injury resulted in a decrease in cortical 
thickness at 4 weeks post injury in female, but not male, mice (summarized in Fig 6.3). Finally, 
we found that repetitive injury significantly decreased the cortical thickness compared to a 
single mild injury in males (summarized in Fig 6.4). 
 
Several notes need to be mentioned in the current study. First, injury related results in chapter 
3 were not replicable in chapter 4. A possible reason for the inconsistences between some 
results presented in Chapter 3 compared to those in Chapter 4 could be the effect of DMSO, 
which was used as the vehicle and vehicle control in the Epothilone investigations. Windrum 
and colleagues have found that reducing the concentration of DMSO prior to treatment could 
significantly alleviate adverse reactions to cells (Windrum et al., 2005), however, further 
studies exploring the effect of DMSO on neurons and astrocytes have reported that there was 
cell toxicity even at low DMSO concentrations, including neurotoxic effects (Wingerchuk and 
Carter, 2014), neurophysiological alterations in pyramidal neurons (Tamagnini et al., 2014), 
and activation of astrocytes (Zhang et al., 2017a). Therefore, in the current study, the 
somewhat inconsistent results in chapter 3 and chapter 4 may due to the detrimental effect of 
DMSO to neurons and glia which may conceal the effect of the injury to the cells. This is an 
unexpected result, given that the DMSO concentration utilized has been used in other 
investigations without detrimental effect being noted (Chuckowree et al., 2018, Clark et al., 
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2018). Further studies investigating various concentrations of DMSO, as well as potential use 
of other vehicles for dissolving the epothilone would be required to definitively determine 
effects. 
 
Second, several potential mechanisms may underly the sex dependent axonal pathology 
noted in the current study. In Dollé and colleagues' study, after culturing female and male axon 
tracts from rat embryos and human iPSC neurons, female axons were consistently smaller 
with fewer microtubules than male axons (Dollé et al., 2018). These structural differences may 
put the microtubules in female axons at greater risk of failure during trauma (Dollé et al., 2018). 
Additionally, the increased presence and absence of testosterone may play a role in sex 
dependent axonal pathology, as Pasaresi and colleagues have reported that manipulating of 
testosterone exposure in rats had significant effects on the size of axon (Pesaresi et al., 2015). 
Furthermore, microglial activation may also play a role. Microglia have been suggested with 
removing the cellular debris in order to help the recovery process after brain injury (Neumann 
et al., 2009). In the current study, the percentage of Iba1 was higher in female cohorts 
compared with male cohorts, which might help female injured axons more quickly recovery. 
Mitochondrial dysfunction has also been associated with axonal damage (Neumann et al., 
2009). Gaignard and colleagues reported that mitochondria in female rodent brains had lower 
oxidative stress compared with those from males, which are associated with greater 
expression and activity of antioxidant enzymes (Gaignard et al., 2015). Thus, sex dependent 
mitochondrial responses may be another reason for sex dependent difference in axonal 
damage. 
 
A potential caveat for this data, is that brain swelling was not evaluated in current studies. 
Using the same injury model as our study in rats, Schneider and colleagues found that the 
mild injury induced significant higher brain edema measured by MRI imaging at both 4 and 8 
hrs after injury, however this difference was resolved at 12 hrs after injury (Schneider et al., 
2002). Moreover, Maegele and colleagues observed that mild to moderate injury produced 
pronounced development of vasogenic edema and cytotoxic edema in brains at 48 hrs after 
injury detected by MRI imaging, however, at 7 days post injury, this edema was also completed 
normalized (Maegele et al., 2015). Therefore, at the timepoints (1 week and 4 weeks post 
injury) when the analysis was performed in the current study, it is likely that injury induced 
brain swelling may be completely resolved, however, future studies using MRI would be 
needed to confirm this. 
 
Furthermore, in the current study, I haven't calculated the essential number of animals to get 
the powerful for parametric tests before the experiments. Therefore, one thing needs to keep 
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in mind is that, the difference between some groups in our study was not statistically different, 
which may due to the limited animal numbers used. Therefore, future follow up studies may 
be strengthened by additional animals per group depending upon outcomes. Following the 
pilot study completed in the current thesis I determined that n=17 per group of animals are 
required to achieve an appropriately powered preclinical trial of Epothilone D with DMSO as 
the vehicle control. Given the novelty of the data, future larger experimental groups are 
required to validate the potential of Epothilone D at treating axonal degeneration. 
 
In summary, the findings in the current thesis suggest that the three risk factors, age, sex and 
additional injury, did not overtly affect the duration of apnoea, the period of unconsciousness, 
and the pyramidal population in the neocortex. However, these factors differentially affected 
the glial and axonal responses after injury (summarized in Fig 6.1, Fig 6.2, Fig 6.3 and Fig 
6.4). Thus, it suggests that the age and sex of the person affected, as well as the potential 
repetitive nature of the injury, should be taken into consideration when making guidelines for 
mTBI patients.  
 
6.1. INFLUENCE OF AGE AND SEX IN OTHER NEUROLOGICAL DISEASE MODELS  
 
The influence of age and sex has been reported in other neurological diseases. In stroke, it 
has been reported that ageing related white matter change is associated with higher risk for 
stroke (Oksala et al., 2009). Additionally, aged animals in ischemic stroke models showed 
worse outcomes including earlier BBB disruption, higher neuronal degeneration and worse 
functional outcomes (Rosen et al., 2005, Dinapoli et al., 2006, DiNapoli et al., 2008). 
Furthermore, the aged are more vulnerable to ischemic injury with more severe white matter 
atrophy, higher axonal degeneration and worse long-term sensorimotor and cognitive deficits 
after stroke (Rosenzweig and Carmichael, 2013, Suenaga et al., 2015). In neurodegenerative 
diseases, it is reported that the ageing of white matter change is strongly correlated with the 
risk of neurodegenerative diseases, with decreased white matter volume, increased white 
matter lesions, impaired white matter integrity and functional network alterations in 
Parkinson’s disease (Watanabe et al., 2013), and white matter ischemia and subsequent white 
matter damage in Alzheimer’s disease (Liu et al., 2017). Moreover, ageing is the most 
significant factor influencing the clinical presentation and disease course and progression of 
Parkinson’s disease (Hindle, 2010, Wyss-Coray, 2016).  
 
The influence of sex on the outcomes after mTBI has been reported. Sex influences the play 
behaviour after mTBI, with females being less engaged in play activities than males 
(Mychasiuk et al., 2014). Additionally, females have been found to be more active and more 
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anxious, with persisting deficits in spatial learning compared to male rodents after mTBI (Wirth 
et al., 2017). Moreover, in Russell and colleagues’ study, they reported that, at 7 to 10 days 
after mTBI in mice, injury decreased c-Fos-immunoreactivity in non-neuroendocrine 
corticotropin-releasing factor (CRF) neurons in the paraventricular nucleus (PVN) in females 
but not in males, which indicates a sex-dependent link to stress dysregulation of preautonomic 
neurons in females and potentially a sex dependent manner of mTBI altered hypothalamic-
pituitary-adrenal (HPA) axis (Russell et al., 2018).  
 
The incidence of stroke is sex dependent with females having a lower incidence compared to 
males at a younger age. Moreover, younger females are more resilient to ischemic brain injury 
compared to younger males rodents (Vannucci et al., 2001). This trend reverses at a later 
age, and overall females suffer more stroke events than men and are less likely to recover 
(Reeves et al., 2008). With regard to Alzheimer’s disease, it is more prevalent in females 
above age 65 years (Irvine et al., 2012), and the cognitive deterioration is worse in females 
(Plassman et al., 2011, Irvine et al., 2012). As to Amyotrophic lateral sclerosis, it is more 
prevalent in males, with increasing risk in post-menopausal females (del Aguila et al., 2003, 
McCombe and Henderson, 2010). In regards to multiple sclerosis, it is more common in 
females, and is faster progressing in males (Confavreux et al., 2003, Voskuhl and Gold, 2012). 
Finally, as to Parkinson’s disease, it is more prevalent in males, with a slower rate of functional 
decline in females (Baldereschi et al., 2000, Elbaz et al., 2002).  
 
6.2. MEASUREMENTS USED IN THE CURRENT STUDY 
 
In the current study, we have used various measurements for axonal degeneration in the 
internal capsule white matter tracts: The percentage area of axonal degeneration indicates 
the percentage area taken by axonal bulbs in the internal capsule; The relative number of the 
axonal fragments in the internal capsule indicates the actual number of dissociated, non-
continuous axonal fragments relative to sham operated mice; The relative the size of the bulbs 
indicates the size of the axonal fragments. As reported in this thesis these three 
measurements are not always consistently changed, with individual changes sometimes 
occurring. Take results in Chapter 3 for example, there were increased percentage of area 
and higher numbers of axonal fragments after injury at 1 week post injury in 1.5 months mice, 
however, there was no significant changes in the size of axonal fragments. This suggests 
there is more axonal degeneration and more fragments but not the size of the fragment in 
young animals at 1 week after injury. Our finding is similar to Mannix and colleagues’ results, 
in which the injury exacerbated white matter loss in adult mice but not in adolescent animals 
at a late time point after repetitive mTBI (Mannix et al., 2017). Furthermore, Pernici and 
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colleagues observed that a subset of undulating axons in the external capsule, caused by 
moderate TBI, returned back to baseline morphology and previously noted varicosities 
disappeared (Pernici et al., 2019). In the current study, axonal degeneration in the internal 
capsule was observed at 1 week post injury but not at 4 weeks post injury in mice injured at 
1.5 months, one possible explanation might be that the degenerated axons at 1 week post 
injury returned back to normal at 4 weeks post injury in 1.5 months mice, which may suggest 
the plasticity of the young brain to mTBI. Additionally, the increased number of fragments in 
the young at 1 week after injury suggests there were higher axonal fragments numbers, 
together with the increased percentage area of fragments, which may indicate the vulnerability 
of the young patient to mTBI at short-term after injury (Emery et al., 2016, Jones et al., 2018, 
Lele et al., 2019). 
 
In the present study, we investigated axonal degeneration in the internal capsule white matter 
tracts, as this is a large white matter tract located directly under the injury site. The corpus 
callosum was considered, but ultimately not used for analysis as we did not observe overt 
axonal degeneration in this region (data not shown). In other studies, exacerbated white 
matter tract loss has been reported after repetitive mTBI in the adult mice (Mannix et al., 2017). 
Additionally, it has also been reported that there is higher rates of axonal degeneration in the 
corpus callosum after repetitive mTBI in aged compared to young brains (Ferguson et al., 
2017b, Mouzon et al., 2018b). In the current study, we used the Thy1-YFPH mice to visualize 
morphological changes in axons. We haven’t used the immunolabelling of APP in our study 
as our preliminary investigations did not reveal overt axonal degeneration by APP 
immunolabelling. This is probably because the accumulated APP in the axons has been 
degraded and cleavage by microglia at the time points investigated (Stone et al., 2002, Iwata 
et al., 2002, Chen et al., 2017). Apart from this, our findings are similar to previous studies 
(Mouzon et al., 2018b, Collins et al., 2019). Collins and colleagues reported that APP 
accumulated in the neuronal processes within the cortex, and within axonal swellings and 
bulbs in the corpus callosum at 24 hrs after mild to moderate TBI in adult mice (Collins et al., 
2019). Moreover, Mouzon and colleagues found that APP immunoreactive axonal profiles 
were observed in the corpus callosum at 24 hours after rmTBI in adult and aged brain injured 
mice (Mouzon et al., 2018b). 
 
Measures of the average thickness of the neocortex at the injured area indicate whether the 
injury caused a major tissue loss or even cavitation. This has been widely observed in the 
brain after moderate and severe TBI (Hakon et al., 2015, Ouyang et al., 2017). However, minor 
neuronal apoptosis and death may not be identified by this measurement. Further studies 
could use specific neuronal degeneration markers to identify this, for example NeuN or Fluoro-
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jade B (FJB). Additionally, MRI could be used as a tool to measure cortical changes in vivo. 
Scholz and colleagues reported that MRI imaging yields evidence of structural changes, they 
found that the hippocampus, frontal cortex and amygdala are larger in rotarod-trained mice 
compared to untrained controls. Moreover, the cerebellum and white matter in the corpus 
callosum underlying the primary motor cortex are smaller after rotarod training (Scholz et al., 
2015). Furthermore, Hammelrath and colleagues reported that the mouse brain volume was 
almost stable at three weeks of age, but thickness of cortex kept decreasing continuously with 
maximal changes during the first three months of mice age detected by in vivo MRI 
(Hammelrath et al., 2016). Thus, MRI could be a potential tool to investigate different 
timepoints after mTBI in mice in the future. Difference of cutting angle during brain slicing may 
exist among different animals, which may influence the results of cortical thickness, therefore, 
other methods could be used, such as MRI imaging which could perform in vivo imaging and 
use less animals. 
 
We did not find any significant dendritic spines changes after injury. By using Golgi-Cox 
staining, Gao and Xiang reported that mTBI significantly decreased the density of mushroom 
and filopodia spines, and increased stubby spines in mice cortex at 3 days after injury (Gao 
and Chen, 2011). Furthermore, by applying in vivo two photon imaging in the mouse brain, 
Kislin and colleagues found that the dendritic segments in the injured cortex contained stable 
spines as well as undergoing spine gain and loss over 2 weeks after the injury (Kislin et al., 
2017). Therefore, in future studies, using other methods for detecting the dendritic spines are 
warranted, including Golgi-Cox staining as well as using in vivo two photon imaging.  
 
6.3. STRENGTHS OF CURRENT STUDY  
 
Although, alternate investigation and analysis protocols can always be applied, there are 
numerous strengths to the current study. Firstly, we used various aged animals of a single 
species in a single study. Moreover, we applied lateral fluid percussion injury in a mouse 
model. This model has been widely used to mimic mTBI, as it induces both diffuse and local 
brain injury, closely resembling human mild brain injury. Additionally, this model is reliable and 
replicable. As it has been reported that the procedure of surgery itself may induce a glial 
response (Lagraoui et al., 2012, Chuckowree et al., 2018), we included sham operated mice 
in our study, which enabled us to eliminate the influence of the surgery itself from our 
interpretation. Furthermore, we investigated cellular and subcellular responses at two 
timepoints after injury, which enable us to investigate both the short and long term response, 
as well as the progress and evolution of the response after injury. Moreover, we used Thy1-
YFPH transgenic mice, which enable us to visualize the neuronal cell body as well as axons 
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and dendrites. Furthermore, we applied various measurements, including the percentage area 
of axonal degeneration, the average size and the relative number of axonal fragments, to 
investigate how the internal capsule white matter tracts response to mTBI. In the current study, 
rather than delivering the epothilone D prior to or immediately after injury, we administered the 
epothilone D at 24 hrs after injury in order to match clinical drug treatment timepoints. 
Additionally, unlike applying a drug in a single aged cohort, we used both young and adult 
mice animals to investigate whether there is age dependent effect of epothilone D treatment. 
As the influence of sex in the context of mTBI is less well studied, we investigated the cellular 
reactions after mTBI in both male and female Thy-YFPH mice. For repetitive injuries, how the 
number of injuries and the time interval between injuries influence the outcomes after 
repetitive mTBI not well investigated. We therefore, investigated how additional injury affects 
the cellular reaction.  
 
6.4. FUTURE DIRECTIONS AND LIMITATIONS  
 
Despite these strengths, there are still some shortcomings in the present study, that should 
be acknowledged and considered when interpreting our findings. Firstly, we only used a single 
mTBI injury model in our study. While the LFPI model has a number of advantages, it is not 
without its disadvantages. The injury process includes anesthesia and craniotomy, which has 
been suggested to affect the cellular and subcellular reactions, and they are seldom observed 
in mTBI patients (Lagraoui et al., 2012, Cole et al., 2011, Wu et al., 2019, Rowe et al., 2013). 
There are other mTBI models, such as the weight drop injury model, cortical controlled injury 
(CCI) model, and blast injury model, however, each has advantages and disadvantages. In 
regards to the weight drop injury model, the advantages include easy manipulation, high 
reproducibility, well-studied neuropathology and the ability to represent graded forms of diffuse 
TBI (Viano et al., 2012). The disadvantages are the possibility of re-hits to the head or body 
of the animals (Mychasiuk et al., 2014), difficulty of skull fixation (Viano et al., 2012) and the 
potentially confounding effects of anaesthesia during the injury procedure (Yurdakoc et al., 
2008). With regard to CCI model, the advantages include the ability to directly control physical 
damage, reliable deficits (Lagraoui et al., 2012), and no rebound concussive events (as seen 
in weight drop model) (Mychasiuk et al., 2014), while a disadvantage of the model is the need 
to perform craniotomies (as seen in fluid percussion injury model). As to the blast injury model, 
the advantages are its high clinical relevance to returning veterans and also its high 
reproducibility. However, disadvantages of the blast injury model include the high price of the 
device and the need for an extensive experimental set up, as well as complications associated 
with the model itself, including intra-parenchymal hemorrhage along the trajectory of the first 
impact (Sato et al., 2014). Thus, no model is perfect at replicating the heterogeneous nature 
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of mTBI in the human population, and new models free from anesthesia and craniotomy are 
needed for use alongside the current LFPI model.   
 
Additionally, even though we induced the injury in the middle between bregma and lambda 
skull suture, we cannot be sure that the site that the injury was delivered to represents the 
exact same anatomic site across the lifespan due to the different sizes of the brains at each 
age point. It has been reported by Rowe and colleagues, that different sized trephines were 
used to attempt to circumvent the potential confounder of age animal at injury (Rowe et al., 
2016). This could be considered for future studies.  
 
In the current study, we investigated both 1 week and 4 weeks post injury time points. 
However, Mouzon and colleagues reported that repetitive mTBI induced stronger astrogliosis 
response and microgliosis response in the corpus callosum at 24 hrs after injury in aged mice. 
Additionally, the injury also caused higher axonal degeneration within the corpus callosum in 
both adult and aged mice (Mouzon et al., 2018b). Furthermore, Monzou and colleagues also 
reported that there was significantly higher axonal degeneration in the corpus callosum, higher 
persisting astrogliosis in the corpus callosum, and higher microgliosis in the corpus callosum 
at 24 months after rmTBI in adult mice (Mouzon et al., 2018c). Thus, investigation of cellular 
changes at less than 1 week and longer than 4 weeks post injury are warranted in future 
studies.  
 
In the current study, we investigated the mice at 1.5, 3 and 12 months of age. In Mannix and 
colleagues’ study, repetitive mTBI was conducted in adolescent mice (5 weeks) and adult 
mice (4 months). They found that injured adolescent mice had longer loss of consciousness 
compared to injured adult mice and the effect of injury was worse in adolescent compared to 
in adult mice with regard to spatial memory (Mannix et al., 2017). In Sandhir and colleagues’ 
study, brain injury was performed in adult and aged mice (22-24 months). In the adult brain, 
they reported increased expression of miR-21 after injury, with the maximum increase at 24 
hrs followed by a gradual decrease, returning to baseline at 7 days post injury. In contrast, 
miR-21 showed no injury response in aged mice (Sandhir et al., 2014). Furthermore, in Ritzel 
and colleagues’ study moderate TBI was performed in young (3 months) and aged (18 
months) mice. They reported that aged mice demonstrated more severe deficits in forelimb 
grip strength, balance, and motor coordination and anxiety like behaviour, as well as more 
robust microglial proliferation at 3 days after injury (Ritzel et al., 2019). Therefore, to better 
understand the influence of age on outcomes after mTBI in a mouse model, future studies 
investigating on mice across the entire lifespan are needed. 
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Additionally, as significant cellular changes have been observed after a single injury in female 
mice in the current study, it would be intriguing in future studies to investigate how the age at 
injury, treatment with EpoD, and additional injury also affects outcomes in female mice. 
Further studies should take the sex hormone level in the females at the time of injury into 
consideration, as female hormones have been suggested to have potentially neuroprotective 
effects in brain injury (Al-Tarrah et al., 2017). In Khaksari and colleagues’ study, brain injury 
was performed in ovariectomized female rats and extra estrogen was administered following 
TBI. At 24 hrs after injury, they reported that the estrogen reduced injury induced brain edema, 
and the edema was attenuated by antagonist of estrogen receptor. Moreover, estrogen 
reduced the level of IL-1β, IL-6, and TNF-α in the injured brain, and the anti-inflammatory 
effect of estrogen was decreased by the antagonist of estrogen receptor. Estrogen also 
increased IL-10 in the injured brain and an antagonist of estrogen receptor resulted in a 
reduction in proinflammatory cytokines (Khaksari et al., 2015). In order to understand the 
underlying mechanisms on how sex influence the inflammation process after mTBI, 
inflammatory factors, such as IL-6, IL-10, TNFα, and C-C Motif Chemokine Ligand 2 (CCL2), 
cyclooxygenase 2 (COX-2) and inducible nitric oxide synthase (iNOS) are needed in future 
studies. 
 
In the current investigation of repetitive brain injury, we did not include sham operated mice. 
For this reason, these studies can only, at this stage be presented as preliminary, or ‘pilot’, 
which makes our study less powerful. The process of the surgery itself has been reported with 
the potential of disrupting the cortex and initiating glial responses (Lagraoui et al., 2012, 
Chuckowree et al., 2018). The repetitive mTBI includes multiple sham process, which could 
influence the cellular response. Therefore, sham operated mice should be included in the 
future.  
 
It is suggested that demyelination and remyelination are important components of white matter 
degeneration in mTBI with axonal injury, in which, oligodendrocyte plays an important role 
(Mierzwa et al., 2015). Mierzwa and colleagues reported that both oligodendrocyte apoptosis 
as well as increased newly differentiated oligodendrocyte were observed at 3 days after mTBI 
in mice (Mierzwa et al., 2015). In the current study, significant increase in the degeneration of 
axons in the internal capsule has been observed after mTBI, therefore, investigating the 
population of oligodendrocyte, including mature and immature oligodendrocyte, may provide 
informative results. 
 
Changes in behavioural and cognitive function has been widely observed as acute and chronic 
responses to mTBI (Mouzon et al., 2018b, Paterno et al., 2018, Zhang et al., 2019). Using the 
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same injury model, at 2 days post injury in rats, injury impairs function on novel object 
recognition test, with injured rats spent less time with the novel object (Jaiswal et al., 2019). 
At 3 days post injury in the rat, there was increased cognitive deficits in the water maze, but 
without difference in beam task, elevated plus maze or open field tests (Wright et al., 2016). 
At 7 days post injury in mice, injured animals had higher freezing rate in conditioned fear 
response compared to sham operated animals (Smith et al., 2012). Therefore, future studies 
performing behavioural tests including novel object recognition test, cognitive test and 
conditioned fear response tests are warranted in future studies. 
 
In the current study, only a single neuronal population was investigated, other neuronal 
populations including interneurons would be influenced by the injury and should be 
investigated in future studies. Brizuela and colleagues have reported that calretinin 
interneurons in injured mice had a reduction in mean dendrite length and a reduction in the 
number of secondary dendrites comparted to those in the sham-injured controls by 7 days 
post-injury, and these alterations evolved over a 28 days period (Brizuela et al., 2017). 
Additionally, Vascak and colleagues reported that parvalbumin interneurons were detected 
across the somatosensory cortex in layers 2-6 at 3 hrs post mTBI (Vascak et al., 2018).  
 
A limitation of the present study, may be the utilisation of the percentage area of positive GFAP 
and Iba1 in the neocortex as a measure of the activation of astrocytes and microglia. 
Previously, GFAP has been used to imply astrocytic activation (Liu et al., 2014, Yu et al., 
2016), similarly, Iba-1 has been used as a marker for the microglial activation in the brains in 
animal studies (Fukuda et al., 2015, Gao et al., 2015, Woodcock and Morganti-Kossmann, 
2015). However, it has also been suggested that even though Iba1 expression is increased 
following mTBI, it is expressed not only in activated microglia but also in resting microglia as 
well as in circulating macrophages in the brain (Walker and Lue, 2015). Classifying microglial 
morphology (such as resting microglia or activated microglia) has been suggested to be a 
good way to imply the states of microglia (Ahmed et al., 2007). This method has been used in 
Chapter 3 (I newly added the data as Fig 3.4 C, D, E), from which, the results from classifying 
the morphology of microglial were similar to the results from measuring the percentage area 
of positive Iba1. In future, applying this microglial morphology analysis to other Chapters to 
confirm the microglial activation results is needed. Furthermore, applying a nuclear 
counterstain, such as DAPI, would also allow assessment of cell density independence of 
immunoreactivity. In addition, in vivo imaging for transgenic mice where astrocytes or 






There are many factors that could influence outcomes after mild traumatic brain injury, 
however, it is still unclear how the age at injury, sex, as well as number of injuries and interval 
between injuries influence the cellular and subcellular reactions after mild traumatic brain 
injury. This thesis demonstrated that glial activation after mTBI was age dependent, with aged 
animals having higher glial activation. Axonal degeneration after mTBI was also age 
dependent, with adult and aged brains showing persisting degeneration that was not in young 
brains (summarized in Fig 6.1). Furthermore, findings of this thesis indicated the age 
dependent axonal and glial responses after mTBI. Additionally, this thesis demonstrated that 
the treatment potential of epothilone D, as a modifier of axonal degeneration, was also age 
dependent, and was found to be ineffective in young mice and detrimental in adult mice 
(summarized in Fig 6.2). Female injured animals showed alleviated cellular reactions 
compared to males, with increased and earlier resolving of axonal pathology after injury 
(summarized in Fig 6.3). Additionally, a second injury at 48 hrs after the initial injury 
significantly increased the cellular reaction and subcellular changes in comparison to a single 
brain injury, with increased glial responses and higher axonal degeneration observed 
(summarized in Fig 6.4). Overall this thesis provides important insight into how age at injury, 
sex, number of injuries and interval between injuries differentially affected neuronal and glial 
reactions to mild traumatic brain injury. Specific cellular and subcellular responses were found 
to differentially characterize pathological changes and recovery processes after mTBI. Thus, 
this thesis further suggests more attention should be spent on addressing these risk factors 
when assessing patients and provides further evidence for the development of individualized 





7.1. Immunohistochemistry solutions 
0.3% Triton/PBS 
600µL Triton X (Sigma, USA) 
200mL 0.01M PBS 
4% Paraformaldehyde (PFA) 
40g PFA (Sigma, USA) 
100mL 9% NaCl 
400mL Na2HPO4 
500mL NaH2PO4.2H2O 
Heat while stirring in a fume hood. 
 
7.2. Normality tests results  
 
Table 1. aging data set (Chapter 3) normality results 
Measurements Graph in thesis Pass normality test 
cortical thickness Fig 3.1 A yes 
YFP+ cell density Fig 3.1 B no 
YFP+ soma size Fig 3.1 C no 
GFAP area Fig 3.1 F yes 
iba-1 area Fig 3.1 G no 
axon percentage of area Fig 3.1 H no 
axon fragment number Fig 3.1 I no 
axon fragment size Fig 3.1 J yes 
total spine density Fig 3.1 K yes 
thin spine density Fig 3.1 L no 
stubby spine density Fig 3.1 M yes 




Table 2. aging with injury data set (Chapter 3) normality results 
Measurements Graph in thesis Pass normality test 
apnoea Fig 3.2 B yes 
righting reflex time Fig 3.2 C yes 
cortical thickness Fig 3.2 D yes 
YFP+ cell density Fig 3.2 E no 
YFP+ soma size Fig 3.2 F yes 
GFAP area Fig 3.3 B no 
iba-1 area Fig 3.4 B no 
resting microglia number Fig 3.4 D no 
activated microglia number Fig 3.4 E no 
axon percentage of area Fig 3.5 B no 
axon fragment number Fig 3.5 C no 
axon fragment size Fig 3.5 D no 
total spine density Fig 3.6 B yes 
thin spine density Fig 3.6 C no 
stubby spine density Fig 3.6 D yes 
mushroom spine density Fig 3.6 E yes 
 
 
Table 3. treatment sham data set (Chapter 4) normality results 
Measurements Graph in thesis Pass normality test 
pulse Fig 4.2 A yes 
apnoea Fig 4.2 B yes 
righting reflex time Fig 4.2 C no 
cortical thickness Fig 4.2 F yes 
YFP+ cell density Fig 4.2 H no 
YFP+ soma size Fig 4.2 J no 
GFAP area Fig 4.3 D yes 
iba-1 area Fig 4.3 F yes 
total spine density Fig 4.5 B no 
thin spine density Fig 4.5 D no 
stubby spine density Fig 4.5 F no 
mushroom spine density Fig 4.5 H yes 
 
 
Table 4. treatment injury data set (Chapter 4) normality results 
Measurements Graph in thesis Pass normality test 
cortical thickness Fig 4.2 E yes 
YFP+ cell density Fig 4.2 G yes 
YFP+ soma size Fig 4.2 I yes 
GFAP area Fig 4.3 C yes 
iba-1 area Fig 4.3 E no 
axon percentage of area Fig 4.4 B yes 
axon fragment number Fig 4.4 C yes 
axon fragment size Fig 4.4 D yes 
total spine density Fig 4.5 A yes 
thin spine density Fig 4.5 C yes 
stubby spine density Fig 4.5 E yes 




Table 5. influence of sex after injury data set (Chapter 5) normality results 
 
 
Table 6. influence of an additional injury data set (Chapter 5) normality results 
Measurements Graph in thesis Pass normality test 
apnoea Fig 5.5 A yes 
righting reflex time Fig 5.5 B yes 
cortical thickness Fig 5.5 C yes 
YFP+ cell density Fig 5.5 D yes 
YFP+ soma size Fig 5.5 E yes 
GFAP area Fig 5.6 B no 
iba-1 area Fig 5.6 C no 
axon percentage of area Fig 5.7 B yes 
axon fragment number Fig 5.7 C yes 
axon fragment size Fig 5.7 D yes 
total spine density Fig 5.8 A yes 
thin spine density Fig 5.8 B yes 
stubby spine density Fig 5.8 C no 
mushroom spine density Fig 5.8 D no 
 
  
Measurements Graph in thesis Pass normality test 
apnoea Fig 5.1 B no 
righting reflex time Fig 5.1 C no 
cortical thickness Fig 5.1 D yes 
YFP+ cell density Fig 5.1 E yes 
YFP+ soma size Fig 5.1 F yes 
GFAP area Fig 5.2 C no 
iba-1 area Fig 5.2 D no 
axon percentage of area Fig 5.3 B no 
axon fragment number Fig 5.3 C no 
axon fragment size Fig 5.3 D yes 
total spine density Fig 5.4 A yes 
thin spine density Fig 5.4 B no 
stubby spine density Fig 5.4 C no 
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